var title_f14_41_14992="Ober test";
var content_f14_41_14992=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F63810&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F63810&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    The Ober test",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 293px; height: 480px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The Ober test assesses the tightness of the iliotibial band (ITB). It is performed with the patient lying on the unaffected side, with the hip and knee of the unaffected leg both positioned in 90 degrees of flexion. The examiner slightly abducts and extends the affected hip and flexes the knee. The patient is then asked to allow the affected leg to fall to the table passively, without actively adducting the hip (just letting it fall with gravity), while the examiner supports the patient's lower leg. Patients with ITB syndrome are more likely to have limited adduction of the leg with this maneuver (positive Ober test).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_41_14992=[""].join("\n");
var outline_f14_41_14992=null;
var title_f14_41_14993="Placental infarct";
var content_f14_41_14993=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F82377&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F82377&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Placental infarct (maternal origin)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 270px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Drucilla J Roberts, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_41_14993=[""].join("\n");
var outline_f14_41_14993=null;
var title_f14_41_14994="Zone 2 blunt injury";
var content_f14_41_14994=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F79392&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F79392&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Forty-five year-old woman with blunt injury to the right eye",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 299px; height: 485px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Clinically she was noted to have subconjunctival hemorrhage superiorly with a conjunctival laceration, hyphema (blood clot in inferior anterior chamber), and iridodialysis (separation of the iris from the ciliary body) superiorly. (B) CT scan showed a hyperdense rim opposed to the sclera representing a scleral buckle from a prior surgery and aphakia (absence of the lens) also from prior surgery. There is significant deformity of the posterior sclera with vitreous volume loss. This woman had a 3 mm scleral laceration 2 mm posterior to the limbus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_41_14994=[""].join("\n");
var outline_f14_41_14994=null;
var title_f14_41_14995="Scabies infant abdomen";
var content_f14_41_14995=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F81770&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F81770&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Scabies, infant",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 303px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Scabies. This infant has papular and vesicular lesions on the trunk.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy;2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_41_14995=[""].join("\n");
var outline_f14_41_14995=null;
var title_f14_41_14996="Celiac ganglion aspirate";
var content_f14_41_14996=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F54517&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F54517&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Celiac ganglion aspirate showing nerve cell bodies",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 319px; height: 442px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Diff Quick. B) Papanicolaou stains.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyrighted and used with permission of Mayo Foundation for Medical Education and Research.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_41_14996=[""].join("\n");
var outline_f14_41_14996=null;
var title_f14_41_14997="Ectopic adrenal adenoma CT";
var content_f14_41_14997=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F70712%7EENDO%2F53633&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F70712%7EENDO%2F53633&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ectopic adrenal adenoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 278px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT image of a 45-year-old woman with ACTH-independent Cushing's syndrome. A 3 x 3 cm mass, which is a benign ectopic adrenal adenoma, is noted near the left renal pelvis (arrow). This patient had undergone previous bilateral adrenalectomy in the mistaken belief that she had bilateral adrenal micronodular hyperplasia. This was followed by 125-I cholesterol scanning on two occasions, which did not detect the ectopic mass.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of David N Orth, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Adrenal cancer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 338px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Contrast-enhanced CT scan through the abdomen of a 56-year-old man reveals a complex solid and cystic, calcified mass (arrow) in the right suprarenal fossa extending into the adjacent liver. The tumor proved at surgery to be a carcinoma of the adrenal cortex.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_41_14997=[""].join("\n");
var outline_f14_41_14997=null;
var title_f14_41_14998="Microinvasive breast carcinoma";
var content_f14_41_14998=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Microinvasive breast carcinoma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/41/14998/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/41/14998/contributors\">",
"     Laura C Collins, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/41/14998/contributors\">",
"     Christine Laronga, MD, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/41/14998/contributors\">",
"     Julia S Wong, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/41/14998/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/41/14998/contributors\">",
"     Lori J Pierce, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/41/14998/contributors\">",
"     Anees B Chagpar, MD, MSc, MA, MPH, FACS, FRCS(C)",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/41/14998/contributors\">",
"     Daniel F Hayes, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/41/14998/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/41/14998/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/41/14998/contributors\">",
"     Don S Dizon, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?14/41/14998/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 21, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H564859980\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Microinvasive breast carcinoma is defined as invasive carcinoma of the breast with no invasive focus measuring more than 1 mm [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/14998/abstract/1\">",
"     1",
"    </a>",
"    ]. It is almost always encountered in the setting of ductal carcinoma in situ (DCIS); thus, it is commonly referred to as ductal carcinoma in situ with microinvasion. It is less commonly seen in association with lobular carcinoma in situ (LCIS) or in the absence of noninvasive disease.",
"   </p>",
"   <p>",
"    The epidemiology, clinical presentation, pathology, and treatment of microinvasive breast carcinoma will be reviewed here. DCIS and LCIS are presented separately.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/43/37561?source=see_link\">",
"       \"Ductal carcinoma in situ: Treatment and prognosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/33/6680?source=see_link\">",
"       \"Breast ductal carcinoma in situ: Epidemiology, clinical manifestations, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/14/44265?source=see_link\">",
"       \"Atypia and lobular carcinoma in situ: High risk lesions of the breast\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/42/16040?source=see_link\">",
"       \"Pathology of breast cancer\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H564859987\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data about the epidemiology and clinical significance of microinvasive breast carcinoma has been limited by its uncommon incidence and the historical lack of a standardized definition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H564859994\">",
"    <span class=\"h2\">",
"     Epidemiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of microinvasive breast carcinoma appears to have increased in parallel with the rising incidence of ductal carcinoma in situ (DCIS), which has been attributed primarily to the introduction of breast cancer screening programs as well as more thorough sampling of breast tissue specimens. Nevertheless, microinvasive breast carcinoma remains an uncommon disease, estimated as accounting for less than 1 percent of all breast cancers [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/14998/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. As with invasive breast cancer, microinvasive breast carcinoma is predominantly ductal in histologic type.",
"   </p>",
"   <p>",
"    Risk factors for microinvasive breast carcinoma appear to be similar to those associated with DCIS, such as nulliparity and family history of breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/14998/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. It occurs over a wide age range (30 to 85 years of age), with the average age in the 50 to 60s [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/14998/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Case series have also suggested that patients diagnosed with microinvasive breast carcinoma have a high incidence of other high-risk lesions, including concurrent breast carcinoma and other malignancies, present at the time of diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/14998/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The epidemiology of DCIS is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/33/6680?source=see_link\">",
"     \"Breast ductal carcinoma in situ: Epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H564860001\">",
"    <span class=\"h2\">",
"     Definition, pathology, and staging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Microinvasive breast carcinoma is defined by the American Joint Committee on Cancer and the International Union for Cancer Control (AJCC-UICC) as invasive carcinoma of the breast with no focus measuring more than 1 mm [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/14998/abstract/1\">",
"     1",
"    </a>",
"    ]. It is almost always encountered in the setting of ductal carcinoma in situ (DCIS), where small foci of tumor cells have invaded through the basement membrane into the surrounding stroma. It is rarely seen in association with lobular carcinoma in situ (LCIS) or in the absence of noninvasive disease [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/14998/abstract/4\">",
"     4",
"    </a>",
"    ]. Where associated with LCIS, the microinvasive component is usually lobular or occasionally tubular in histologic type.",
"   </p>",
"   <p>",
"    According to the 2010 AJCC-UICC TNM staging system, microinvasive breast carcinoma is designated as T1mi, as presented in the table (",
"    <a class=\"graphic graphic_table graphicRef65393 \" href=\"UTD.htm?29/14/29920\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/14998/abstract/1\">",
"     1",
"    </a>",
"    ]. In cases with multiple foci of microinvasion (where no focus is larger than 1 mm), the number of foci and range of sizes should be reported. Note that the sizes of individual foci of microinvasion are not added together. Since microinvasive breast carcinoma is more likely to present with multiple foci of invasion, the pathologic specimen should be carefully examined for additional foci [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/14998/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Histopathologically, microinvasive breast carcinoma tends to be associated with high-grade DCIS and comedo type necrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/14998/abstract/2,5,6\">",
"     2,5,6",
"    </a>",
"    ]. There is also evidence that the risk of microinvasion increases with larger size DCIS lesions and multicentric DCIS [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/14998/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/42/16040?source=see_link\">",
"     \"Pathology of breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is little information about biological markers (ie, hormone receptor status and human epidermal growth factor receptor 2 (HER2) overexpression) in microinvasive breast carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/14998/abstract/2,7\">",
"     2,7",
"    </a>",
"    ]. In a study including 30 patients who had complete hormone receptor testing of both the invasive and in situ components,",
"    <span class=\"nowrap\">",
"     ER/PR-positivity",
"    </span>",
"    was 100 percent concordant in both microinvasive and in situ disease; ER-negativity was 83 percent concordant. HER2 status was 100 percent concordant [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/14998/abstract/7\">",
"     7",
"    </a>",
"    ]. Contrary to invasive breast cancer, the limited data suggest that receptor expression has little prognostic significance in microinvasive breast cancer. (See",
"    <a class=\"local\" href=\"#H564860043\">",
"     'Prognosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H564860008\">",
"    <span class=\"h2\">",
"     Clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast to DCIS, which is most often diagnosed due to abnormal mammographic findings, microinvasive breast carcinoma more commonly presents as a palpable mass [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/14998/abstract/2-6\">",
"     2-6",
"    </a>",
"    ]. The mass usually represents an area of DCIS with stromal desmoplasia; the microinvasion in and of itself is not palpable. Nipple discharge may also occur.",
"   </p>",
"   <p>",
"    Some studies suggest that the most frequent imaging appearance of microinvasive breast carcinoma is a mass, with or without calcifications, whereas others have found that similar to DCIS, the most frequent imaging appearance is calcifications [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/14998/abstract/2\">",
"     2",
"    </a>",
"    ]. These different results are likely due to differences between studies in the definition of microinvasive breast carcinoma used, which imaging studies were performed (ie, mammography or ultrasonography), and degree of tissue sampling.",
"   </p>",
"   <p>",
"    Most diagnostic biopsies are performed as core needle biopsies. As such, pathology results may reveal DCIS &ldquo;suspicious for&rdquo; microinvasion. It is only when the entire specimen is removed that a final diagnosis of microinvasive breast carcinoma can be rendered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/59/24504?source=see_link&amp;anchor=H4#H4\">",
"     \"Breast biopsy\", section on 'Core needle biopsy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H564860015\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest that BCS followed by RT is a reasonable treatment approach for most patients with microinvasive breast carcinoma. However, mastectomy may be preferred for patients in whom the DCIS component is large, high-grade,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    comedo type",
"    <strong>",
"     and",
"    </strong>",
"    in whom clean margins cannot be definitively obtained with BCS.",
"   </p>",
"   <p>",
"    Although simple mastectomy achieves an excellent \"cure\" rate for microinvasive breast carcinoma, it likely provides overly aggressive treatment for many women. Although breast conserving surgery (BCS) may be associated with an increased risk of local recurrence, radiation therapy (RT) after BCS minimizes this risk. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/7/11385?source=see_link\">",
"     \"Role of radiation therapy in breast conservation therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H564860022\">",
"    <span class=\"h2\">",
"     Management of the breast",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no randomized trials to inform the optimal surgical treatment for microinvasive breast carcinoma. As with invasive cancer and pure DCIS, BCS followed by RT to the whole breast (together referred to as breast conserving therapy, BCT) is the most common approach. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/43/37561?source=see_link\">",
"     \"Ductal carcinoma in situ: Treatment and prognosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/42/31402?source=see_link\">",
"     \"Breast conserving therapy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/18/12586?source=see_link\">",
"     \"Mastectomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As with DCIS and early invasive breast cancer, BCT for microinvasive breast carcinoma appears to achieve excellent outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/14998/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. In a retrospective study of 321 patients with DCIS and 72 patients with microinvasion treated with BCT, the presence of microinvasion did not correlate with local recurrence rate, distant relapse free survival, or overall survival at almost nine years of follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/14998/abstract/8\">",
"     8",
"    </a>",
"    ]. The improved outcomes in contemporary series may be due at least in part to the use of adjuvant endocrine therapy for patients whose disease is estrogen receptor (ER)-positive.",
"   </p>",
"   <p>",
"    The risk of recurrence following BCT for microinvasive disease appears to be increased with:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Positive excision margins [",
"      <a class=\"abstract\" href=\"UTD.htm?14/41/14998/abstract/7,9\">",
"       7,9",
"      </a>",
"      ] (See",
"      <a class=\"local\" href=\"#H564860043\">",
"       'Prognosis'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Size of the DCIS component [",
"      <a class=\"abstract\" href=\"UTD.htm?14/41/14998/abstract/3,4\">",
"       3,4",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Unfavorable histopathologic characteristics, ie, comedo subtype and high nuclear grade [",
"      <a class=\"abstract\" href=\"UTD.htm?14/41/14998/abstract/6\">",
"       6",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Consequently, As described above, these characteristics are common with microinvasive breast carcinoma. (See",
"    <a class=\"local\" href=\"#H564859987\">",
"     'Overview'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H564860029\">",
"    <span class=\"h2\">",
"     Management of the axilla",
"    </span>",
"    &nbsp;&mdash;&nbsp;The reported incidence of axillary lymph node involvement in microinvasive breast carcinoma ranges from 0 to 20 percent, but is often 5 percent or less for clearly defined microinvasive breast carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/14998/abstract/4,5,9-16\">",
"     4,5,9-16",
"    </a>",
"    ]. The likelihood of axillary node involvement is greater in cases where stromal invasion is demonstrated by clusters of cells rather than single cells [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/14998/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the majority of patients with microinvasive breast carcinoma are likely to have negative axillary lymph nodes, we recommend that sentinel lymph node biopsy (SLNB) should be performed for patients with microinvasion because the assessment of axillary lymph node status may impact adjuvant therapy decisions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/47/36602?source=see_link\">",
"     \"Sentinel lymph node dissection for breast cancer: Indications and outcomes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H564860036\">",
"    <span class=\"h2\">",
"     Adjuvant systemic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There have been no clinical trials specifically addressing the role of adjuvant endocrine therapy, chemotherapy,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/39/6776?source=see_link\">",
"     trastuzumab",
"    </a>",
"    in the treatment of microinvasive breast carcinoma. In the absence of definitive data, we extrapolate from the treatment paradigms for non-metastatic breast cancer.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Adjuvant endocrine therapy is appropriate for most women with hormone receptor (HR)-positive microinvasive breast cancer. The approach to these patients is similar to that for women in invasive HR-positive breast cancer. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20106?source=see_link\">",
"       \"Adjuvant endocrine therapy for hormone receptor-positive breast cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The approach to chemotherapy is similar to the treatment approach for women with non-metastatic, invasive breast cancer. Given that by definition these patients have a primary breast tumor &le;1 mm, we would offer chemotherapy to women with microinvasive breast cancer if there was pathological node involvement identified. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/4/37961?source=see_link\">",
"       \"Adjuvant chemotherapy for hormone receptor-positive or negative, HER2-negative breast cancer\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/7/11384?source=see_link\">",
"       \"Adjuvant medical therapy for HER2-positive breast cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The limited data suggest there is no prognostic significance of hormone",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      human epidermal growth factor 2 (HER2) receptor expression. (See",
"      <a class=\"local\" href=\"#H564860043\">",
"       'Prognosis'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The evidence underlying these recommendations for adjuvant therapy for early stage breast cancer is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/46/19177?source=see_link\">",
"     \"Overview of the treatment of newly diagnosed, non-metastatic breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H564860043\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Microinvasive breast carcinoma has an excellent prognosis, with a five-year overall survival between 97 and 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/14998/abstract/6\">",
"     6",
"    </a>",
"    ].",
"    <strong>",
"    </strong>",
"    Survival seems to be intermediate between pure DCIS and small invasive carcinomas, likely closer to that of DCIS.",
"   </p>",
"   <p>",
"    For women with microinvasive carcinoma, the risk of recurrence following surgery (BCT or mastectomy) appears to be small. In one study of 83 patients followed for a median of six years, the cumulative incidence of recurrence at five years was five percent [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/14998/abstract/7\">",
"     7",
"    </a>",
"    ]. The post-excision finding of close or positive margins (&le;2 mm) on pathologic evaluation was the only factor associated with an increased risk of a local recurrence, which were diagnosed in 4 of 20 patients who had a close margin versus 2 of 62 who had a negative margin (HR 8.8, 95% CI 1.6-48.8). This small study also reported that the expression of HR",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    HER2 was not associated with the risk of axillary node involvement at diagnosis or the risk of recurrence.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?3/26/3492?source=see_link\">",
"       \"Patient information: Ductal carcinoma in situ (DCIS) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H564860050\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Microinvasive breast carcinoma is defined as invasive carcinoma of the breast with no focus measuring more than 1 mm; it is almost always encountered in the setting of ductal carcinoma in situ (DCIS).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The risk of microinvasive breast carcinoma increases with larger size DCIS lesions and multicentric DCIS. It tends to be associated with high-grade and comedo type DCIS and is more likely to present with multiple foci of microinvasion. (See",
"      <a class=\"local\" href=\"#H564859987\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      According to the 2010 AJCC-UICC TNM staging system, microinvasive breast carcinoma is designated as T1mi. (See",
"      <a class=\"local\" href=\"#H564859987\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The optimal treatment for microinvasive breast cancer is undefined. We suggest breast conserving surgery (BCS) followed by radiation therapy (RT) to reduce the risk of local recurrence (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). However, mastectomy may be preferred for patients at high risk of local recurrence with BCT, including those with extensive, multicentric, high-grade,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      comedo type DCIS, and for those patients when histologically clear margins cannot be obtained with BCS. (See",
"      <a class=\"local\" href=\"#H564860022\">",
"       'Management of the breast'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that sentinel lymph node biopsy (SLNB) be performed for patients with confirmed microinvasive breast carcinoma (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). SLNB is associated with minimal morbidity and assessment of axillary lymph node status may impact adjuvant therapy decisions. (See",
"      <a class=\"local\" href=\"#H564860029\">",
"       'Management of the axilla'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For most women with hormone receptor-positive microinvasive breast cancer who have no evidence of pathological node involvement, we suggest adjuvant endocrine therapy (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). However, for patients",
"      <strong>",
"       with",
"      </strong>",
"      pathological node involvement at diagnosis, we recommend adjuvant endocrine therapy (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). The treatment approach is similar to that used for women with invasive breast cancer. (See",
"      <a class=\"local\" href=\"#H564860036\">",
"       'Adjuvant systemic therapy'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/46/19177?source=see_link\">",
"       \"Overview of the treatment of newly diagnosed, non-metastatic breast cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For women with pathological node involvement, we suggest adjuvant chemotherapy (in addition to endocrine therapy for women with hormone receptor-positive disease) (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ).",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/39/6776?source=see_link\">",
"       Trastuzumab",
"      </a>",
"      should be added to adjuvant chemotherapy in this setting for women with HER2-overexpressing tumors. (See",
"      <a class=\"local\" href=\"#H564860036\">",
"       'Adjuvant systemic therapy'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/46/19177?source=see_link\">",
"       \"Overview of the treatment of newly diagnosed, non-metastatic breast cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Microinvasive breast carcinoma has an excellent prognosis, with a greater than 95 percent five-year overall survival. (See",
"      <a class=\"local\" href=\"#H564860043\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     (American Joint Committee on Cancer) Cancer Staging Manual, 7th edition, Edge SB, Byrd DR, Compton CC, et al (Eds), Springer, New York 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/14998/abstract/2\">",
"      Vieira CC, Mercado CL, Cangiarella JF, et al. Microinvasive ductal carcinoma in situ: clinical presentation, imaging features, pathologic findings, and outcome. Eur J Radiol 2010; 73:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/14998/abstract/3\">",
"      Padmore RF, Fowble B, Hoffman J, et al. Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience. Cancer 2000; 88:1403.",
"     </a>",
"    </li>",
"    <li>",
"     Silverstein MJ, Lagios MD. Ductal carcinoma in situ with microinvasion. In: Ductal Carcinoma in Situ of the Breast, Silverstein MJ (Ed), Lippincott Williams and Wilkins, Philadelphia 2002. p.523.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/14998/abstract/5\">",
"      de Mascarel I, MacGrogan G, Mathoulin-P&eacute;lissier S, et al. Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas. Cancer 2002; 94:2134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/14998/abstract/6\">",
"      Adamovich TL, Simmons RM. Ductal carcinoma in situ with microinvasion. Am J Surg 2003; 186:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/14998/abstract/7\">",
"      Margalit DN, Sreedhara M, Chen YH, et al. Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy. Ann Surg Oncol 2013; 20:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/14998/abstract/8\">",
"      Parikh RR, Haffty BG, Lannin D, Moran MS. Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation. Int J Radiat Oncol Biol Phys 2012; 82:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/14998/abstract/9\">",
"      Solin LJ, Fowble BL, Yeh IT, et al. Microinvasive ductal carcinoma of the breast treated with breast-conserving surgery and definitive irradiation. Int J Radiat Oncol Biol Phys 1992; 23:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/14998/abstract/10\">",
"      Silver SA, Tavassoli FA. Mammary ductal carcinoma in situ with microinvasion. Cancer 1998; 82:2382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/14998/abstract/11\">",
"      Wong JH, Kopald KH, Morton DL. The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer. Arch Surg 1990; 125:1298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/14998/abstract/12\">",
"      Prasad ML, Osborne MP, Giri DD, Hoda SA. Microinvasive carcinoma (T1mic) of the breast: clinicopathologic profile of 21 cases. Am J Surg Pathol 2000; 24:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/14998/abstract/13\">",
"      Wong SL, Chao C, Edwards MJ, et al. Frequency of sentinel lymph node metastases in patients with favorable breast cancer histologic subtypes. Am J Surg 2002; 184:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/14998/abstract/14\">",
"      Klauber-DeMore N, Tan LK, Liberman L, et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol 2000; 7:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/14998/abstract/15\">",
"      Zavagno G, Belardinelli V, Marconato R, et al. Sentinel lymph node metastasis from mammary ductal carcinoma in situ with microinvasion. Breast 2007; 16:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/14998/abstract/16\">",
"      Pimiento JM, Lee MC, Esposito NN, et al. Role of axillary staging in women diagnosed with ductal carcinoma in situ with microinvasion. J Oncol Pract 2011; 7:309.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14221 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.247-9662981F41-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_41_14998=[""].join("\n");
var outline_f14_41_14998=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H564860050\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H564859980\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H564859987\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H564859994\">",
"      Epidemiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H564860001\">",
"      Definition, pathology, and staging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H564860008\">",
"      Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H564860015\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H564860022\">",
"      Management of the breast",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H564860029\">",
"      Management of the axilla",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H564860036\">",
"      Adjuvant systemic therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H564860043\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H564860050\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/14221\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/14221|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/14/29920\" title=\"table 1\">",
"      TNM stage breast cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/4/37961?source=related_link\">",
"      Adjuvant chemotherapy for hormone receptor-positive or negative, HER2-negative breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20106?source=related_link\">",
"      Adjuvant endocrine therapy for hormone receptor-positive breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/7/11384?source=related_link\">",
"      Adjuvant medical therapy for HER2-positive breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/14/44265?source=related_link\">",
"      Atypia and lobular carcinoma in situ: High risk lesions of the breast",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/59/24504?source=related_link\">",
"      Breast biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/42/31402?source=related_link\">",
"      Breast conserving therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/33/6680?source=related_link\">",
"      Breast ductal carcinoma in situ: Epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/43/37561?source=related_link\">",
"      Ductal carcinoma in situ: Treatment and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/18/12586?source=related_link\">",
"      Mastectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/46/19177?source=related_link\">",
"      Overview of the treatment of newly diagnosed, non-metastatic breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/42/16040?source=related_link\">",
"      Pathology of breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?3/26/3492?source=related_link\">",
"      Patient information: Ductal carcinoma in situ (DCIS) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/7/11385?source=related_link\">",
"      Role of radiation therapy in breast conservation therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/47/36602?source=related_link\">",
"      Sentinel lymph node dissection for breast cancer: Indications and outcomes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_41_14999="Pemphigoid gestationis bull";
var content_f14_41_14999=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F72690%7EDERM%2F52776&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F72690%7EDERM%2F52776&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pemphigoid gestationis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 351px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple tense bullae are present on the skin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pemphigoid gestationis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Widespread erythematous plaques, bullae, and erosions are present on this patient with extensive disease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_41_14999=[""].join("\n");
var outline_f14_41_14999=null;
var title_f14_41_15000="Causes of hypomagnesemia";
var content_f14_41_15000=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Causes of hypomagnesemia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/41/15000/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/41/15000/contributors\">",
"     Alan S L Yu, MB, BChir",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/41/15000/contributors\">",
"     Gunjeet K Kala Ahluwalia, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/41/15000/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/41/15000/contributors\">",
"     Stanley Goldfarb, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/41/15000/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/41/15000/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?14/41/15000/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 20, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H8658039\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypomagnesemia is a common entity occurring in up to 12 percent of hospitalized patients [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/1\">",
"     1",
"    </a>",
"    ]. The incidence rises to as high as 60 to 65 percent in patients in an intensive care setting in which nutrition, diuretics, hypoalbuminemia, and aminoglycosides may play important roles [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]. The kidney can, in the presence of magnesium depletion, lower magnesium excretion to very low levels; the stimulus for this response is a fall in the plasma magnesium concentration. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/29/470?source=see_link\">",
"     \"Regulation of magnesium balance\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are two major mechanisms by which hypomagnesemia can be induced: gastrointestinal or renal losses. Regardless of the cause, hypomagnesemia begins to occur after a relatively small magnesium deficit because there is little rapid exchange of extracellular magnesium with the much larger bone and cell stores.",
"   </p>",
"   <p>",
"    Hypomagnesemia is often associated with hypokalemia (due to urinary potassium wasting) and hypocalcemia (due both to lower parathyroid hormone secretion and end-organ resistance to its effect). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42580?source=see_link\">",
"     \"Signs and symptoms of magnesium depletion\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The major causes of hypomagnesemia will be reviewed in this topic. The regulation of magnesium balance, the signs and symptoms of hypomagnesemia, and the evaluation and treatment of patients with hypomagnesemia are presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/29/470?source=see_link\">",
"     \"Regulation of magnesium balance\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42580?source=see_link\">",
"     \"Signs and symptoms of magnesium depletion\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/63/11254?source=see_link\">",
"     \"Evaluation and treatment of hypomagnesemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8658046\">",
"    <span class=\"h1\">",
"     GASTROINTESTINAL LOSSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastrointestinal secretions contain some magnesium, and potential losses are continuous and not regulated. Although the obligatory losses are not large, marked dietary deprivation can lead to progressive magnesium depletion.",
"   </p>",
"   <p>",
"    Magnesium losses from both the upper and lower gastrointestinal tract can induce hypomagnesemia. In general, magnesium depletion is more commonly due to diarrhea than to vomiting [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/5\">",
"     5",
"    </a>",
"    ]. This is because the magnesium content of lower tract secretions is significantly higher (up to 15",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    versus approximately 1",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    for upper tract). Common settings in which hypomagnesemia may be seen include acute or chronic diarrhea, malabsorption and steatorrhea, and small bowel bypass surgery.",
"   </p>",
"   <p>",
"    In addition, hypomagnesemia with secondary hypocalcemia can be produced by a familial disorder characterized by a selective defect in magnesium absorption (primary intestinal hypomagnesemia). This disease presents in the neonatal period with hypocalcemia that is responsive to magnesium administration [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/6\">",
"     6",
"    </a>",
"    ]. In some instances, the defect appears to have an X-linked recessive inheritance, but others have described autosomally recessive inheritance with linkage to chromosome 9 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/7\">",
"     7",
"    </a>",
"    ]. The autosomal recessive form is caused by mutations in the TRPM6 gene [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/8-12\">",
"     8-12",
"    </a>",
"    ]. The encoded protein, which is expressed both by intestinal epithelia and by the renal distal convoluted tubule, functions as an apical magnesium entry channel [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/13\">",
"     13",
"    </a>",
"    ]. Thus, patients with this disorder have not only decreased intestinal magnesium absorption, but also inappropriate renal magnesium wasting.",
"   </p>",
"   <p>",
"    Hypomagnesemia can also be seen in acute pancreatitis. The mechanism of hypomagnesemia is presumably similar to the mechanism partially responsible for hypocalcemia in acute pancreatitis: saponification of magnesium and calcium in necrotic fat [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/14\">",
"     14",
"    </a>",
"    ]. The degree of hypocalcemia may be exacerbated by the hypomagnesemia, which can both lower parathyroid hormone secretion and induce end-organ resistance to its effect. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/25/24984?source=see_link\">",
"     \"Etiology of hypocalcemia in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42580?source=see_link\">",
"     \"Signs and symptoms of magnesium depletion\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8658053\">",
"    <span class=\"h2\">",
"     Proton pump inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypomagnesemia, usually with hypocalcemia, has been described in case reports with the chronic use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/62/26601?source=see_link\">",
"     omeprazole",
"    </a>",
"    (usually for more than one year) and other proton pump inhibitors (PPIs) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/15-18\">",
"     15-18",
"    </a>",
"    ]. It is not clear why only a small proportion of patients treated with PPIs develop hypomagnesemia.",
"   </p>",
"   <p>",
"    The presumed mechanism of hypomagnesemia is impaired intestinal absorption since urinary magnesium excretion is appropriately low in such patients [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. Some patients have inappropriately low serum parathyroid hormone levels [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/16\">",
"     16",
"    </a>",
"    ], a finding that is well described in patients with hypomagnesemia due to other causes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42580?source=see_link&amp;anchor=H5#H5\">",
"     \"Signs and symptoms of magnesium depletion\", section on 'Hypocalcemia and hypoparathyroidism'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In March 2011, the United States Food and Drug Administration (FDA) issued a safety warning suggesting that, in patients expected to be on PPIs for long periods of time and in those taking other medications associated with hypomagnesemia as described below, providers measure serum magnesium levels prior to initiation of PPI therapy and periodically during treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/19\">",
"     19",
"    </a>",
"    ]. The hypomagnesemia can be partially or completely corrected by high-dose oral magnesium supplementation [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. Hypomagnesemia resolves with cessation of PPI therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/15,16,18\">",
"     15,16,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8658060\">",
"    <span class=\"h1\">",
"     RENAL LOSSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urinary magnesium losses can occur via a variety of either acquired or intrinsic mechanisms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/29/470?source=see_link\">",
"     \"Regulation of magnesium balance\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8658067\">",
"    <span class=\"h2\">",
"     Medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both loop and thiazide diuretics can inhibit net magnesium reabsorption, while potassium-sparing diuretics may enhance magnesium transport and lower magnesium excretion. The degree of hypomagnesemia induced by loop and thiazide diuretics is generally mild, in part because the associated volume contraction will tend to increase proximal sodium, water, and magnesium reabsorption. A more detailed review of how these changes might occur is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/41/43668?source=see_link\">",
"     \"Diuretics and magnesium balance\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to loop and thiazide diuretics, many nephrotoxic drugs can produce urinary magnesium wasting [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/20\">",
"     20",
"    </a>",
"    ], including but not limited to:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Aminoglycoside antibiotics (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/34/24104?source=see_link&amp;anchor=H28#H28\">",
"       \"Aminoglycosides\", section on 'Nephrotoxicity'",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"       Amphotericin B",
"      </a>",
"      (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/5/38998?source=see_link\">",
"       \"Amphotericin B nephrotoxicity\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"       Cisplatin",
"      </a>",
"      (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/8/29833?source=see_link\">",
"       \"Cisplatin nephrotoxicity\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/43/22199?source=see_link\">",
"       Pentamidine",
"      </a>",
"      (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/4/4168?source=see_link&amp;anchor=H15534424#H15534424\">",
"       \"Overview of kidney disease in HIV-infected patients\", section on 'Electrolyte disorders'",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"       Cyclosporine",
"      </a>",
"      (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/61/41945?source=see_link\">",
"       \"Cyclosporine and tacrolimus nephrotoxicity\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Antibodies targeting the epidermal growth factor (EGF) receptor (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/58/10151?source=see_link\">",
"       cetuximab",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/48/6918?source=see_link\">",
"       panitumumab",
"      </a>",
"      , matuzumab) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/48/41738?source=see_link\">",
"       \"Chemotherapy-related nephrotoxicity and dose modification in patients with renal insufficiency\"",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The impairment in loop and distal magnesium reabsorption may occur prior to the onset of, and may persist after the resolution of, the acute tubular necrosis and acute kidney injury (AKI) associated with these nephrotoxins. Studies in the rat, for example, have shown a dose-related and rapidly reversible decrease in renal tubular reabsorption of magnesium and calcium (but not sodium and potassium) within 60 minutes of beginning an infusion of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/21\">",
"     21",
"    </a>",
"    ]. The hypermagnesuria in this setting can be striking, and the resulting hypomagnesemia may be sufficient to produce hypocalcemia. With",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    therapy, a reduction in gastrointestinal magnesium absorption may also contribute to the hypomagnesemia [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8658074\">",
"    <span class=\"h2\">",
"     Volume expansion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Expansion of the extracellular fluid volume, by reducing reabsorption of sodium and water, can decrease passive magnesium transport. Mild hypomagnesemia may ensue if this is sustained, as in primary aldosteronism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37911?source=see_link\">",
"     \"Clinical features of primary aldosteronism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8658081\">",
"    <span class=\"h2\">",
"     Alcohol",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypomagnesemia is common in alcoholic patients admitted to the hospital; in one study, for example, the prevalence was 30 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/23\">",
"     23",
"    </a>",
"    ]. Excessive urinary excretion of magnesium occurred in 18 of the 38 patients with hypomagnesemia. The defect in urinary excretion appears to reflect alcohol-induced tubular dysfunction that is reversible within four weeks of abstinence [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/24\">",
"     24",
"    </a>",
"    ]. This effect is relatively modest, and other factors are also thought to contribute to hypomagnesemia in these patients, including dietary deficiency, acute pancreatitis, and diarrhea.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8658088\">",
"    <span class=\"h2\">",
"     Uncontrolled diabetes mellitus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypomagnesemia is not uncommon in patients with uncontrolled diabetes mellitus; it appears to be associated with increased urinary magnesium excretion that is reversed by correction of the hyperglycemia with insulin [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/5,25,26\">",
"     5,25,26",
"    </a>",
"    ]. It has been proposed, although not proven, that hypomagnesemia may impair glucose disposal and may play a role in the pathogenesis of some of the complications of diabetes. As a result, the American Diabetes Association (ADA) has published a consensus statement suggesting that diabetic patients with hypomagnesemia should receive magnesium supplementation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8658095\">",
"    <span class=\"h2\">",
"     Hypercalcemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with hypercalcemia due, for example, to hyperparathyroidism can develop mild hypomagnesemia. This finding results at least in part from the fact that calcium and magnesium functionally compete for transport in the thick ascending limb of the loop of Henle. A variety of mechanisms may contribute to the reduction in magnesium reabsorption resulting from hypercalcemia. One well-established mechanism is mediated by the basolateral calcium-sensing receptor (CaSR) in the thick ascending limb:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Calcium binds to the basolateral CaSR.",
"     </li>",
"     <li>",
"      This leads to generation of prostaglandins and cytochrome P450 metabolites in the cell, which inhibit the apical potassium channel (ROMK) [",
"      <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/27,28\">",
"       27,28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Inhibition of ROMK inhibits sodium chloride reabsorption in the thick ascending limb and reduces paracellular magnesium and calcium reabsorption (",
"      <a class=\"graphic graphic_figure graphicRef75301 \" href=\"UTD.htm?30/62/31725\">",
"       figure 1",
"      </a>",
"      ). Inhibition of ROMK in this nephron segment resulting from stimulation of the CaSR is the mechanism underlying type V Bartter syndrome. Thus, hypercalcemia can produce a Bartter-like phenotype. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/43/23226?source=see_link&amp;anchor=H88846693#H88846693\">",
"       \"Bartter and Gitelman syndromes\", section on 'Type V'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In addition, stimulation of the CaSR decreases paracellular permeability of the thick ascending limb to both magnesium and calcium [",
"      <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/29\">",
"       29",
"      </a>",
"      ], likely due to increased expression of claudin-14 [",
"      <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/30,31\">",
"       30,31",
"      </a>",
"      ], which negatively regulates claudin-16 and claudin-19. (See",
"      <a class=\"local\" href=\"#H8658123\">",
"       'Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC)'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8658102\">",
"    <span class=\"h2\">",
"     Other acquired tubular dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Magnesium wasting can be seen as part of the tubular dysfunction associated with recovery from acute tubular necrosis, following renal transplantation, or during a postobstructive diuresis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8658109\">",
"    <span class=\"h2\">",
"     Familial renal magnesium wasting",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary renal magnesium wasting is an unusual disorder that may present sporadically or as a familial disease [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/32-36\">",
"     32-36",
"    </a>",
"    ]. Several types have been recognized [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis of primary renal magnesium wasting is one of",
"    <strong>",
"     exclusion",
"    </strong>",
"    . It is established by the demonstration of inappropriately high urinary magnesium excretion in the absence of any other apparent cause. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/63/11254?source=see_link\">",
"     \"Evaluation and treatment of hypomagnesemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8658116\">",
"    <span class=\"h3\">",
"     Gitelman syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gitelman syndrome is the most common form of familial renal magnesium wasting and is usually associated with salt wasting, hypokalemic metabolic alkalosis, and",
"    <strong>",
"     hypocalciuria",
"    </strong>",
"    . It is caused by recessive mutations in the gene coding for the thiazide-sensitive sodium chloride cotransporter (SLC12A3). Although the hypokalemia in this syndrome is usually attributed to decreased sodium chloride transport, direct effects of hypomagnesemia may also contribute [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/38\">",
"     38",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/43/23226?source=see_link\">",
"     \"Bartter and Gitelman syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The hypomagnesemia in Gitelman syndrome is significantly more marked than that observed with thiazide administration. In addition, mice lacking the sodium chloride cotransporter had hypomagnesemia and hypocalciuria but exhibited only subtle changes in sodium homeostasis [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8658123\">",
"    <span class=\"h3\">",
"     Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC)",
"    </span>",
"    &nbsp;&mdash;&nbsp;This form of primary renal magnesium wasting is autosomal recessive and associated with",
"    <strong>",
"     hypercalciuria",
"    </strong>",
"    ; affected patients usually present in childhood or adolescence with symptomatic hypocalcemia [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/40-44\">",
"     40-44",
"    </a>",
"    ]. Recurrent nephrolithiasis and nephrocalcinosis are also seen, and progression to renal insufficiency and an acidification defect are common. The problem with acidification has been attributed to defective ammonia transfer to the deep nephrons and impaired medullary hydrogen ion secretion due to nephrocalcinosis [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/45\">",
"     45",
"    </a>",
"    ]. Affected patients may also have polyuria and polydipsia due to nephrogenic diabetes insipidus [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/40,44\">",
"     40,44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mutations in the claudin-16 gene (also known as paracellin-1) are the major cause of FHHNC [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/12,44,46-50\">",
"     12,44,46-50",
"    </a>",
"    ]. Claudin-16 is a tight junction protein that facilitates the passive, paracellular reabsorption of both magnesium and calcium in the thick ascending limb of the loop of Henle. Some of these patients present with hypokalemia due to either secondary hyperaldosteronism",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    direct effects of hypomagnesemia on potassium transport.",
"   </p>",
"   <p>",
"    FHHNC may occasionally be due to mutations in claudin-19 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/51\">",
"     51",
"    </a>",
"    ]. In addition to hypomagnesemia, nephrolithiasis, and nephrocalcinosis, such patients have ocular involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/52\">",
"     52",
"    </a>",
"    ], which may include macular colobomata, nystagmus, and myopia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8658130\">",
"    <span class=\"h3\">",
"     Na-K-ATPase mutation",
"    </span>",
"    &nbsp;&mdash;&nbsp;A gene responsible for autosomal dominant isolated renal magnesium wasting in two unrelated Dutch families has been mapped to a region on chromosome 11q23 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/53\">",
"     53",
"    </a>",
"    ]. The abnormality in this disorder appears to be a dominant negative mutation in the gene encoding the gamma subunit of Na-K-ATPase, resulting in misrouting of the protein [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/54,55\">",
"     54,55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8658137\">",
"    <span class=\"h3\">",
"     Voltage gated potassium channel",
"    </span>",
"    &nbsp;&mdash;&nbsp;A mutation in the gene (KCNA1) that encodes the voltage-gated potassium channel (Kv1.1) is the cause of isolated autosomal dominant hypomagnesemia discovered in a large Brazilian family [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/56\">",
"     56",
"    </a>",
"    ]. This channel colocalizes with the magnesium channel TRPM6 in the distal collecting tubules. Wild type Kv1.1 appears to control TRPM6 magnesium reabsorption via the creation of an appropriate potential across the luminal membrane.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8658144\">",
"    <span class=\"h3\">",
"     Hepatocyte nuclear factor-1-beta gene mutations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypomagnesemia and renal magnesium wasting have been reported in 8 of 18 patients (44 percent) with known mutations in the hepatocyte nuclear factor-1-beta (HNF-1-beta) gene [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/57\">",
"     57",
"    </a>",
"    ]. HNF-1-beta is a transcription factor that regulates the expression of the gamma subunit of Na-K-ATPase. These findings suggest that some mutations of HNF-1-beta can activate this subunit, thereby causing hypomagnesemia, in association with early onset diabetes and renal malformations that include multicystic dysplastic disease and obstructive uropathy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/33/14874?source=see_link\">",
"     \"Classification of diabetes mellitus and genetic diabetic syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8658151\">",
"    <span class=\"h3\">",
"     Epidermal growth factor gene mutation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epidermal growth factor (EGF) appears to stimulate distal tubular magnesium reabsorption by binding to a receptor on the basolateral membrane and activating the magnesium channel TRPM6 in the apical membrane. A point mutation in pro-EGF leads to impaired basolateral membrane sorting, inadequate stimulation of renal EGF receptor, insufficient activation of the magnesium channel, and causes isolated autosomal recessive renal magnesium wasting [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. A similar inhibition of the EGF receptor likely underlies the effects of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/58/10151?source=see_link\">",
"     cetuximab",
"    </a>",
"    and other EGF receptor inhibitors on magnesium transport as previously mentioned [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H8658067\">",
"     'Medications'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8658158\">",
"    <span class=\"h3\">",
"     Cyclin M2 mutations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mutations in the cyclin M2 (CNNM2) gene have been implicated in two families with dominant isolated renal magnesium wasting [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/60\">",
"     60",
"    </a>",
"    ]. CNNM2 encodes a transmembrane protein that is localized to the basolateral membrane of the thick ascending limb and distal convoluted tubule; it functions either as a magnesium channel [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/61\">",
"     61",
"    </a>",
"    ] or magnesium-sensitive sodium channel and is upregulated under conditions of magnesium deficiency.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8658165\">",
"    <span class=\"h1\">",
"     MISCELLANEOUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypomagnesemia has been described in a number of other settings. The following is a partial list of potential causes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intravascular chelation can lead to hypomagnesemia and has been described in the following settings:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Following surgery, at least in part due to chelation by circulating free fatty acids [",
"      <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/62\">",
"       62",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      After",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/56/29575?source=see_link\">",
"       foscarnet",
"      </a>",
"      therapy of cytomegalovirus chorioretinitis, often in association with hypocalcemia [",
"      <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/63\">",
"       63",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Ionized hypomagnesemia during liver transplantation due to transfusion of citrate-rich blood products in the absence of adequate hepatic function to metabolize the citrate [",
"      <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/64\">",
"       64",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypomagnesemia can occur as part of the \"hungry bone\" syndrome in which there is increased magnesium uptake by renewing bone following parathyroidectomy for hyperparathyroidism, thyroidectomy for hyperthyroidism, or correction of severe metabolic acidosis [",
"      <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/65\">",
"       65",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/13/3287?source=see_link\">",
"       \"Hungry bone syndrome following parathyroidectomy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hypomagnesemia has been found in up to 10 percent of patients placed on an extremely high-fat diet to induce ketogenesis as the therapy of intractable epilepsy. The mechanism of this effect is not clear but may result from malabsorption of magnesium [",
"      <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/66\">",
"       66",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/52/2890?source=see_link\">",
"       \"Evaluation and management of drug-resistant epilepsy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hypomagnesemia, in combination with hypertension and dyslipidemia, was described in a kindred with a mutation in mitochondrial tRNA [",
"      <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/67\">",
"       67",
"      </a>",
"      ]. The mutation likely resulted in multiple and varied physiologic disruptions because of its effect on energy consumption. With respect to low magnesium levels, distal convoluted tubule cells could be adversely affected because magnesium reabsorption requires significant energy.",
"     </li>",
"     <li>",
"      Hypomagnesemia has been associated with leptospirosis and may be due at least in part to urinary magnesium wasting [",
"      <a class=\"abstract\" href=\"UTD.htm?14/41/15000/abstract/68,69\">",
"       68,69",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8658172\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypomagnesemia is a common entity occurring in up to 12 percent of hospitalized patients. The incidence rises to as high as 60 to 65 percent in patients in an intensive care setting. There are two major mechanisms by which hypomagnesemia can be induced: gastrointestinal or renal losses. (See",
"      <a class=\"local\" href=\"#H8658039\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Gastrointestinal secretions contain some magnesium. Although the obligatory losses are not large, marked dietary deprivation can lead to progressive magnesium depletion. Magnesium losses from both the upper and lower gastrointestinal tract can induce hypomagnesemia. Common settings in which hypomagnesemia may be seen include acute or chronic diarrhea, malabsorption and steatorrhea, and small bowel bypass surgery. Hypomagnesemia can also be seen in acute pancreatitis. (See",
"      <a class=\"local\" href=\"#H8658046\">",
"       'Gastrointestinal losses'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hypomagnesemia has been described with the chronic use of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/62/26601?source=see_link\">",
"       omeprazole",
"      </a>",
"      (usually for more than one year) and other proton pump inhibitors (PPIs), presumably due to impaired intestinal absorption. The United States Food and Drug Administration (FDA) issued a safety warning suggesting that, in patients expected to be on these drugs for long periods of time and in those taking other medications associated with hypomagnesemia, providers should measure serum magnesium levels prior to initiation of therapy and periodically during treatment. (See",
"      <a class=\"local\" href=\"#H8658053\">",
"       'Proton pump inhibitors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Urinary magnesium losses can occur via a variety of either acquired or intrinsic mechanisms. These include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Medications, including loop and thiazide diuretics and various potential nephrotoxins (see",
"      <a class=\"local\" href=\"#H8658067\">",
"       'Medications'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Sustained expansion of the extracellular fluid volume, as with primary aldosteronism (see",
"      <a class=\"local\" href=\"#H8658074\">",
"       'Volume expansion'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Alcohol use (see",
"      <a class=\"local\" href=\"#H8658081\">",
"       'Alcohol'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Uncontrolled diabetes mellitus (see",
"      <a class=\"local\" href=\"#H8658088\">",
"       'Uncontrolled diabetes mellitus'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Hypercalcemia, as in patients with primary hyperparathyroidism (see",
"      <a class=\"local\" href=\"#H8658095\">",
"       'Hypercalcemia'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Recovery from acute kidney injury (AKI) and following renal transplantation (see",
"      <a class=\"local\" href=\"#H8658102\">",
"       'Other acquired tubular dysfunction'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Familial renal magnesium wasting, such as with Gitelman syndrome (see",
"      <a class=\"local\" href=\"#H8658109\">",
"       'Familial renal magnesium wasting'",
"      </a>",
"      above).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H96091283\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The authors and UpToDate would like to thank Dr. Zalman Agus, who contributed to earlier versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/1\">",
"      Wong ET, Rude RK, Singer FR, Shaw ST Jr. A high prevalence of hypomagnesemia and hypermagnesemia in hospitalized patients. Am J Clin Pathol 1983; 79:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/2\">",
"      Chernow B, Bamberger S, Stoiko M, et al. Hypomagnesemia in patients in postoperative intensive care. Chest 1989; 95:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/3\">",
"      Desai TK, Carlson RW, Geheb MA. Prevalence and clinical implications of hypocalcemia in acutely ill patients in a medical intensive care setting. Am J Med 1988; 84:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/4\">",
"      Ryzen E. Magnesium homeostasis in critically ill patients. Magnesium 1989; 8:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/5\">",
"      Tong GM, Rude RK. Magnesium deficiency in critical illness. J Intensive Care Med 2005; 20:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/6\">",
"      Paunier L, Radde IC, Kooh SW, et al. Primary hypomagnesemia with secondary hypocalcemia in an infant. Pediatrics 1968; 41:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/7\">",
"      Walder RY, Shalev H, Brennan TM, et al. Familial hypomagnesemia maps to chromosome 9q, not to the X chromosome: genetic linkage mapping and analysis of a balanced translocation breakpoint. Hum Mol Genet 1997; 6:1491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/8\">",
"      Schlingmann KP, Weber S, Peters M, et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 2002; 31:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/9\">",
"      Walder RY, Landau D, Meyer P, et al. Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat Genet 2002; 31:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/10\">",
"      Huang CL. The transient receptor potential superfamily of ion channels. J Am Soc Nephrol 2004; 15:1690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/11\">",
"      Schlingmann KP, Sassen MC, Weber S, et al. Novel TRPM6 mutations in 21 families with primary hypomagnesemia and secondary hypocalcemia. J Am Soc Nephrol 2005; 16:3061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/12\">",
"      Guran T, Akcay T, Bereket A, et al. Clinical and molecular characterization of Turkish patients with familial hypomagnesaemia: novel mutations in TRPM6 and CLDN16 genes. Nephrol Dial Transplant 2012; 27:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/13\">",
"      Voets T, Nilius B, Hoefs S, et al. TRPM6 forms the Mg2+ influx channel involved in intestinal and renal Mg2+ absorption. J Biol Chem 2004; 279:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/14\">",
"      Ryzen E, Rude RK. Low intracellular magnesium in patients with acute pancreatitis and hypocalcemia. West J Med 1990; 152:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/15\">",
"      Hess MW, Hoenderop JG, Bindels RJ, Drenth JP. Systematic review: hypomagnesaemia induced by proton pump inhibition. Aliment Pharmacol Ther 2012; 36:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/16\">",
"      Epstein M, McGrath S, Law F. Proton-pump inhibitors and hypomagnesemic hypoparathyroidism. N Engl J Med 2006; 355:1834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/17\">",
"      Broeren MA, Geerdink EA, Vader HL, van den Wall Bake AW. Hypomagnesemia induced by several proton-pump inhibitors. Ann Intern Med 2009; 151:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/18\">",
"      Cundy T, Dissanayake A. Severe hypomagnesaemia in long-term users of proton-pump inhibitors. Clin Endocrinol (Oxf) 2008; 69:338.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm245275.htm (Accessed on March 08, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/20\">",
"      Shah GM, Kirschenbaum MA. Renal magnesium wasting associated with therapeutic agents. Miner Electrolyte Metab 1991; 17:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/21\">",
"      Foster JE, Harpur ES, Garland HO. An investigation of the acute effect of gentamicin on the renal handling of electrolytes in the rat. J Pharmacol Exp Ther 1992; 261:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/22\">",
"      Lajer H, Kristensen M, Hansen HH, et al. Magnesium and potassium homeostasis during cisplatin treatment. Cancer Chemother Pharmacol 2005; 55:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/23\">",
"      Elisaf M, Merkouropoulos M, Tsianos EV, Siamopoulos KC. Pathogenetic mechanisms of hypomagnesemia in alcoholic patients. J Trace Elem Med Biol 1995; 9:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/24\">",
"      De Marchi S, Cecchin E, Basile A, et al. Renal tubular dysfunction in chronic alcohol abuse--effects of abstinence. N Engl J Med 1993; 329:1927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/25\">",
"      Tosiello L. Hypomagnesemia and diabetes mellitus. A review of clinical implications. Arch Intern Med 1996; 156:1143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/26\">",
"      White JR Jr, Campbell RK. Magnesium and diabetes: a review. Ann Pharmacother 1993; 27:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/27\">",
"      Wang WH, Lu M, Hebert SC. Cytochrome P-450 metabolites mediate extracellular Ca(2+)-induced inhibition of apical K+ channels in the TAL. Am J Physiol 1996; 271:C103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/28\">",
"      Wang W, Lu M, Balazy M, Hebert SC. Phospholipase A2 is involved in mediating the effect of extracellular Ca2+ on apical K+ channels in rat TAL. Am J Physiol 1997; 273:F421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/29\">",
"      Loupy A, Ramakrishnan SK, Wootla B, et al. PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor. J Clin Invest 2012; 122:3355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/30\">",
"      Gong Y, Renigunta V, Himmerkus N, et al. Claudin-14 regulates renal Ca������ transport in response to CaSR signalling via a novel microRNA pathway. EMBO J 2012; 31:1999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/31\">",
"      Dimke H, Desai P, Borovac J, et al. Activation of the Ca2+-sensing receptor increases renal claudin-14 expression and urinary Ca2+ excretion. Am J Physiol Renal Physiol 2013; 304:F761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/32\">",
"      Evans RA, Carter JN, George CR, et al. The congenital \"magnesium-losing kidney\". Report of two patients. Q J Med 1981; 50:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/33\">",
"      Geven WB, Monnens LA, Willems JL. Magnesium metabolism in childhood. Miner Electrolyte Metab 1993; 19:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/34\">",
"      Freeman RM, Pearson E. Hypomagnesemia of unknown etiology. Am J Med 1966; 41:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/35\">",
"      Runeberg L, Collan Y, Jokinen EJ, et al. Hypomagnesemia due to renal disease of unknown etiology. Am J Med 1975; 59:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/36\">",
"      Booth BE, Johanson A. Hypomagnesemia due to renal tubular defect in reabsorption of magnesium. J Pediatr 1974; 85:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/37\">",
"      Konrad M, Weber S. Recent advances in molecular genetics of hereditary magnesium-losing disorders. J Am Soc Nephrol 2003; 14:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/38\">",
"      Kamel KS, Harvey E, Douek K, et al. Studies on the pathogenesis of hypokalemia in Gitelman's syndrome: role of bicarbonaturia and hypomagnesemia. Am J Nephrol 1998; 18:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/39\">",
"      Schultheis PJ, Lorenz JN, Meneton P, et al. Phenotype resembling Gitelman's syndrome in mice lacking the apical Na+-Cl- cotransporter of the distal convoluted tubule. J Biol Chem 1998; 273:29150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/40\">",
"      Praga M, Vara J, Gonz&aacute;lez-Parra E, et al. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int 1995; 47:1419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/41\">",
"      Nicholson JC, Jones CL, Powell HR, et al. Familial hypomagnesaemia--hypercalciuria leading to end-stage renal failure. Pediatr Nephrol 1995; 9:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/42\">",
"      Benigno V, Canonica CS, Bettinelli A, et al. Hypomagnesaemia-hypercalciuria-nephrocalcinosis: a report of nine cases and a review. Nephrol Dial Transplant 2000; 15:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/43\">",
"      M&uuml;ller D, Kausalya PJ, Bockenhauer D, et al. Unusual clinical presentation and possible rescue of a novel claudin-16 mutation. J Clin Endocrinol Metab 2006; 91:3076.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/44\">",
"      Konrad M, Hou J, Weber S, et al. CLDN16 genotype predicts renal decline in familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol 2008; 19:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/45\">",
"      Rodr&iacute;guez-Soriano J, Vallo A. Pathophysiology of the renal acidification defect present in the syndrome of familial hypomagnesaemia-hypercalciuria. Pediatr Nephrol 1994; 8:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/46\">",
"      Simon DB, Lu Y, Choate KA, et al. Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 1999; 285:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/47\">",
"      Blanchard A, Jeunemaitre X, Coudol P, et al. Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle. Kidney Int 2001; 59:2206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/48\">",
"      Weber S, Schneider L, Peters M, et al. Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol 2001; 12:1872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/49\">",
"      Kausalya PJ, Amasheh S, G&uuml;nzel D, et al. Disease-associated mutations affect intracellular traffic and paracellular Mg2+ transport function of Claudin-16. J Clin Invest 2006; 116:878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/50\">",
"      Godron A, Harambat J, Boccio V, et al. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: phenotype-genotype correlation and outcome in 32 patients with CLDN16 or CLDN19 mutations. Clin J Am Soc Nephrol 2012; 7:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/51\">",
"      Hou J, Renigunta A, Konrad M, et al. Claudin-16 and claudin-19 interact and form a cation-selective tight junction complex. J Clin Invest 2008; 118:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/52\">",
"      Konrad M, Schaller A, Seelow D, et al. Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet 2006; 79:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/53\">",
"      Meij IC, Saar K, van den Heuvel LP, et al. Hereditary isolated renal magnesium loss maps to chromosome 11q23. Am J Hum Genet 1999; 64:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/54\">",
"      Meij IC, Koenderink JB, van Bokhoven H, et al. Dominant isolated renal magnesium loss is caused by misrouting of the Na(+),K(+)-ATPase gamma-subunit. Nat Genet 2000; 26:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/55\">",
"      Meij IC, Koenderink JB, De Jong JC, et al. Dominant isolated renal magnesium loss is caused by misrouting of the Na+,K+-ATPase gamma-subunit. Ann N Y Acad Sci 2003; 986:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/56\">",
"      Glaudemans B, van der Wijst J, Scola RH, et al. A missense mutation in the Kv1.1 voltage-gated potassium channel-encoding gene KCNA1 is linked to human autosomal dominant hypomagnesemia. J Clin Invest 2009; 119:936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/57\">",
"      Adalat S, Woolf AS, Johnstone KA, et al. HNF1B mutations associate with hypomagnesemia and renal magnesium wasting. J Am Soc Nephrol 2009; 20:1123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/58\">",
"      Wagner CA. Disorders of renal magnesium handling explain renal magnesium transport. J Nephrol 2007; 20:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/59\">",
"      Groenestege WM, Th&eacute;bault S, van der Wijst J, et al. Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia. J Clin Invest 2007; 117:2260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/60\">",
"      Stuiver M, Lainez S, Will C, et al. CNNM2, encoding a basolateral protein required for renal Mg2+ handling, is mutated in dominant hypomagnesemia. Am J Hum Genet 2011; 88:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/61\">",
"      Goytain A, Quamme GA. Functional characterization of ACDP2 (ancient conserved domain protein), a divalent metal transporter. Physiol Genomics 2005; 22:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/62\">",
"      Aglio LS, Stanford GG, Maddi R, et al. Hypomagnesemia is common following cardiac surgery. J Cardiothorac Vasc Anesth 1991; 5:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/63\">",
"      Palestine AG, Polis MA, De Smet MD, et al. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med 1991; 115:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/64\">",
"      Scott VL, De Wolf AM, Kang Y, et al. Ionized hypomagnesemia in patients undergoing orthotopic liver transplantation: a complication of citrate intoxication. Liver Transpl Surg 1996; 2:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/65\">",
"      Frisch LS, Mimouni F. Hypomagnesemia following correction of metabolic acidosis: a case of hungry bones. J Am Coll Nutr 1993; 12:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/66\">",
"      Kang HC, Chung DE, Kim DW, Kim HD. Early- and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia 2004; 45:1116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/67\">",
"      Wilson FH, Hariri A, Farhi A, et al. A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science 2004; 306:1190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/68\">",
"      Sitprija V. Altered fluid, electrolyte and mineral status in tropical disease, with an emphasis on malaria and leptospirosis. Nat Clin Pract Nephrol 2008; 4:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15000/abstract/69\">",
"      Spichler A, Athanazio DA, Furtado J, et al. Case report: severe, symptomatic hypomagnesemia in acute leptospirosis. Am J Trop Med Hyg 2008; 79:915.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 829 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-D40D2B0C78-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_41_15000=[""].join("\n");
var outline_f14_41_15000=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8658172\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8658039\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8658046\">",
"      GASTROINTESTINAL LOSSES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8658053\">",
"      Proton pump inhibitors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8658060\">",
"      RENAL LOSSES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8658067\">",
"      Medications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8658074\">",
"      Volume expansion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8658081\">",
"      Alcohol",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8658088\">",
"      Uncontrolled diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8658095\">",
"      Hypercalcemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8658102\">",
"      Other acquired tubular dysfunction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8658109\">",
"      Familial renal magnesium wasting",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8658116\">",
"      - Gitelman syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8658123\">",
"      - Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8658130\">",
"      - Na-K-ATPase mutation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8658137\">",
"      - Voltage gated potassium channel",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8658144\">",
"      - Hepatocyte nuclear factor-1-beta gene mutations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8658151\">",
"      - Epidermal growth factor gene mutation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8658158\">",
"      - Cyclin M2 mutations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8658165\">",
"      MISCELLANEOUS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8658172\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H96091283\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/829\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/829|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?30/62/31725\" title=\"figure 1\">",
"      Loop of Henle transport",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/34/24104?source=related_link\">",
"      Aminoglycosides",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/5/38998?source=related_link\">",
"      Amphotericin B nephrotoxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/43/23226?source=related_link\">",
"      Bartter and Gitelman syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/48/41738?source=related_link\">",
"      Chemotherapy-related nephrotoxicity and dose modification in patients with renal insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/8/29833?source=related_link\">",
"      Cisplatin nephrotoxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/33/14874?source=related_link\">",
"      Classification of diabetes mellitus and genetic diabetic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37911?source=related_link\">",
"      Clinical features of primary aldosteronism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/61/41945?source=related_link\">",
"      Cyclosporine and tacrolimus nephrotoxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/41/43668?source=related_link\">",
"      Diuretics and magnesium balance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/25/24984?source=related_link\">",
"      Etiology of hypocalcemia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/52/2890?source=related_link\">",
"      Evaluation and management of drug-resistant epilepsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/63/11254?source=related_link\">",
"      Evaluation and treatment of hypomagnesemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/13/3287?source=related_link\">",
"      Hungry bone syndrome following parathyroidectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/4/4168?source=related_link\">",
"      Overview of kidney disease in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/29/470?source=related_link\">",
"      Regulation of magnesium balance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42580?source=related_link\">",
"      Signs and symptoms of magnesium depletion",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_41_15001="Pharmacology of amphotericin B";
var content_f14_41_15001=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pharmacology of amphotericin B",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/41/15001/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/41/15001/contributors\">",
"     Richard H Drew, PharmD, MS, BCPS, FCCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/41/15001/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/41/15001/contributors\">",
"     Carol A Kauffman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/41/15001/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/41/15001/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?14/41/15001/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     Amphotericin B",
"    </a>",
"    is a polyene antifungal agent with activity in vitro against a wide variety of fungal pathogens [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/1\">",
"     1",
"    </a>",
"    ]. Amphotericin B exerts its antifungal effect by disruption of fungal cell wall synthesis because of its ability to bind to sterols, primarily ergosterol, which leads to the formation of pores that allow leakage of cellular components. This affinity may also account for its toxic effects against select mammalian cells. Amphotericin B is generally considered cidal against susceptible fungi at clinically relevant concentrations.",
"   </p>",
"   <p>",
"    Despite the introduction of newer antifungal agents for the treatment of systemic mycoses,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    remains the standard treatment for many severe, invasive fungal infections. However, because of toxicities associated with its intravenous use, along with the expanded availability of safer treatment options, it is frequently reserved for patients who have severe, life-threatening invasive fungal infections or are unable to tolerate alternative antifungal agents.",
"   </p>",
"   <p>",
"    The pharmacology of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    will be reviewed here. The nephrotoxicity and the clinical uses of amphotericin B are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/5/38998?source=see_link\">",
"     \"Amphotericin B nephrotoxicity\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/13/29914?source=see_link\">",
"     \"Treatment of candidemia and invasive candidiasis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/18/28970?source=see_link\">",
"     \"Treatment and prevention of invasive aspergillosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/42/3753?source=see_link\">",
"     \"Treatment and prevention of Fusarium infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/8/13449?source=see_link\">",
"     \"Cryptococcal infection outside the central nervous system\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/61/40919?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of cryptococcal meningoencephalitis in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/54/15210?source=see_link\">",
"     \"Treatment of cryptococcal meningoencephalitis and disseminated infection in HIV seronegative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/13/29912?source=see_link\">",
"     \"Treatment of blastomycosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/23/21881?source=see_link\">",
"     \"Diagnosis and treatment of pulmonary histoplasmosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/6/9321?source=see_link\">",
"     \"Diagnosis and treatment of disseminated histoplasmosis in non-HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/26/1449?source=see_link\">",
"     \"Diagnosis and treatment of histoplasmosis in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/46/6890?source=see_link\">",
"     \"Mucormycosis (zygomycosis)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/51/39734?source=see_link\">",
"     \"Management of pulmonary sequelae and complications of coccidioidomycosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/11/26807?source=see_link\">",
"     \"Manifestations and treatment of extrapulmonary coccidioidomycosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21848?source=see_link\">",
"     \"Coccidioidomycosis in compromised hosts\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/55/17271?source=see_link\">",
"     \"Coccidioidal meningitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/0/34822?source=see_link\">",
"     \"Treatment of sporotrichosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SPECTRUM OF ACTIVITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Activity of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    has been demonstrated in vitro against a wide variety of clinical fungal isolates, including most Candida spp, Aspergillus spp, the Mucorales, all of the endemic mycoses, and most hyaline and brown-black molds. Activity has also been demonstrated against the Leishmania [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Organisms that are usually resistant to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    &nbsp;include the organisms that cause chromoblastomycosis, Aspergillus terreus, Candida lusitaniae, Scedosporium spp, and some Fusarium spp&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/2-6\">",
"     2-6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H248502\">",
"    <span class=\"h1\">",
"     AMPHOTERICIN B DEOXYCHOLATE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Pharmacokinetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite over 40 years of clinical use, relatively little is known about the pharmacokinetics of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/7\">",
"     7",
"    </a>",
"    ]. The pharmacokinetic profiles of the lipid-based formulations of amphotericin B differ from those of amphotericin B deoxycholate and from each other. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Lipid-based amphotericin B formulations'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Absorption",
"    </span>",
"    &nbsp;&mdash;&nbsp;The drug is poorly absorbed (less than 5 percent) after oral administration. As a result, treatment of invasive mycoses requires intravenous administration. An oral suspension (no longer commercially available in the United States) is useful only in the treatment of oropharyngeal candidiasis and is generally reserved for those infections that are refractory to other agents. Systemic absorption following aerosol administration is also thought to be minimal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Distribution",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum concentrations following intravenous infusions of 30 to 50 mg of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    deoxycholate have ranged from 1 to 2",
"    <span class=\"nowrap\">",
"     mcg/mL.",
"    </span>",
"    The drug is highly protein bound (up to 95 percent), primarily to lipoproteins. It is extensively distributed throughout the body, with a volume of distribution of approximately 4",
"    <span class=\"nowrap\">",
"     L/kg.",
"    </span>",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     Amphotericin B",
"    </a>",
"    concentrations can be measured in various body tissues and fluids, including liver, spleen, pleural fluid, peritoneal fluid, joint, vitreous body, and aqueous humor. Poor penetration into inflamed and uninflamed meninges has been reported, despite demonstrated clinical efficacy in central nervous system (CNS) fungal infections, such as cryptococcal meningitis and other fungal infections [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Metabolism/elimination",
"    </span>",
"    &nbsp;&mdash;&nbsp;No metabolites have been identified. Drug elimination is biphasic, with a terminal half-life of up to 15 days. The primary route of elimination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    is not known; urine and biliary excretion account for less than 5 percent of the administered dose. Serum levels are not influenced by hepatic or renal function, or by hemodialysis or peritoneal dialysis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Dosing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Doses of IV",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    deoxycholate range from 0.1 to 1.5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day. Doses of 0.1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day of amphotericin B deoxycholate have been investigated as prophylaxis in high-risk patients [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. However, this practice has largely been replaced by alternative agents with less toxicity. The usual dose for most invasive mycoses is 0.5 to 1.0",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day; doses exceeding 1.0",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day are generally reserved for treatment of mucormycosis and azole-refractory invasive coccidioidomycosis (such as meningitis). Daily doses of 1.5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day should not be exceeded. Pathogen- and disease-specific dosing recommendations have been published by the Infectious Diseases Society of America (IDSA) for many invasive mycoses. The IDSA clinical practice guidelines can be accessed at the IDSA's website [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/10\">",
"     10",
"    </a>",
"    ]. The recommended dosing of amphotericin B for each fungal disease and infection site is discussed in detail separately. (See",
"    <a class=\"local\" href=\"#H1\">",
"     'Introduction'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    does not need to be adjusted for renal dysfunction. However, in the setting of renal dysfunction, alternate day therapy of twice the daily dose has been described. However, with the advent of lipid-based formulations, such a dosing strategy is rarely employed in current practice.",
"   </p>",
"   <p>",
"    The dosing of lipid formulations of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    is discussed below. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Dosing'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Method of administration",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     Amphotericin B",
"    </a>",
"    is most commonly administered intravenously, but direct or local instillation of amphotericin B has been used in several clinical circumstances.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H439193761\">",
"    <span class=\"h3\">",
"     Intravenous",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intravenous infusions are prepared by combining",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    with 5 percent dextrose in water (D5W) at a final concentration of 0.1",
"    <span class=\"nowrap\">",
"     mg/mL.",
"    </span>",
"    Although the incidence of acute hypersensitivity reactions from amphotericin B is rare, a test dose of 1 mg has been recommended. The test dose can be given as an aliquot of the initial infusion, followed by the remainder of the dose if there is no apparent reaction within 30 minutes. However, tolerance of the test dose does not exclude other amphotericin B toxicities.",
"   </p>",
"   <p>",
"    Infusion times are traditionally four to six hours.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     Amphotericin B",
"    </a>",
"    has been given over shorter time periods (eg, 45 to 60 minutes), but infusion-related reactions (such as fever) may be more frequent and this method is not recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/11\">",
"     11",
"    </a>",
"    ]. The practice of titrating the daily dose to the target dose over several days has not been proven to lessen adverse reactions and may delay optimal therapy.",
"   </p>",
"   <p>",
"    Intravenous administration of the total daily dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    given as a continuous infusion over 24 hours has been associated with less nephrotoxicity compared with administration over four hours [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/12\">",
"     12",
"    </a>",
"    ]. However, the efficacy of this administration schedule for patients with established infections has not been proven. Furthermore, amphotericin B exhibits concentration-dependent pharmacodynamics that may be compromised by continuous infusion. Continuous infusion of amphotericin B is not FDA-approved and is not recommended.",
"   </p>",
"   <p>",
"    Administration of premedications to patients receiving",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    should be considered to prevent infusion-related reactions and nephrotoxicity. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Adverse effects'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H439193603\">",
"    <span class=\"h3\">",
"     Bladder irrigation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Irrigation of the bladder with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    has been used in the treatment of candiduria. There have been several non-blinded randomized trials comparing amphotericin B bladder irrigation with oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/12/16586?source=see_link\">",
"     fluconazole",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. Although the use of amphotericin B bladder irrigation resulted in clearing of candiduria in many patients, relapses were routinely observed after several weeks. Traditionally, 50 mg of amphotericin B has been added to 1000 mL sterile water for irrigation and given as a continuous bladder irrigation daily for a period of five days. However, this regimen requires the presence of an indwelling bladder catheter, which itself is a risk factor for candiduria. Shorter treatment courses (one day) or reduced doses (as low as 5",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    have been recommended by some authors [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. Current published guidelines on the treatment of candiduria do not recommend the use of amphotericin B bladder irrigation, except in exceptional circumstances [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H439193798\">",
"    <span class=\"h3\">",
"     Intraperitoneal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Local instillation of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    has also been reported in the treatment of fungal peritonitis (alone or in combination with intravenous therapy). This practice is discouraged because it causes abdominal pain and can contribute to adhesion formation and loss of the peritoneum as a dialyzing membrane. Patients with fungal peritonitis should be treated with catheter removal and systemic antifungal therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/27/8631?source=see_link&amp;anchor=H6#H6\">",
"     \"Fungal peritonitis in continuous peritoneal dialysis\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H463493101\">",
"    <span class=\"h3\">",
"     Intrathecal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intrathecal administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    deoxycholate in the lumbar subarachnoid space has been used primarily for the treatment of coccidioidal meningitis. Target doses generally range from 0.1 to 1.5 mg at intervals ranging from daily to weekly [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/18\">",
"     18",
"    </a>",
"    ]; lower doses (ie, 0.01 mg) can be started and increased slowly until target doses are reached or the patient shows signs of intolerance [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/19\">",
"     19",
"    </a>",
"    ]. Adverse effects resulting from intrathecal administration are frequent and include, but are not limited to, nausea and vomiting, headache, back",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    leg pain, loss of bowel",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bladder control, and nerve palsies. The development of arachnoiditis is a serious complication of this form of therapy.",
"   </p>",
"   <p>",
"    Intrathecal",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    deoxycholate can also be given through a ventricular Ommaya or Rickham reservoir. The target dose range is the same as for intrathecal administration in the lumbar subarachnoid space (0.1 to 1.5 mg daily to weekly). Severe vomiting, headache, and prostration can occur, and bacterial infection of the reservoir has been reported.",
"   </p>",
"   <p>",
"    Cisternal administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    deoxycholate, either through a reservoir or by direct injection, is used in some cases of coccidioidal meningitis in order to attain drug levels in the basilar meninges, where the infection is localized [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/18\">",
"     18",
"    </a>",
"    ]. The dose range is the same as for intrathecal and intraventricular administration noted above. Severe headache, vomiting, prostration, and even death have been reported following intracisternal injection of amphotericin B [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/18,20\">",
"     18,20",
"    </a>",
"    ]. Only experts at cisternal injections should undertake this form of therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/55/17271?source=see_link&amp;anchor=H14#H14\">",
"     \"Coccidioidal meningitis\", section on 'Antifungal therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H439193919\">",
"    <span class=\"h3\">",
"     Intravitreal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intravitreal and intracameral (into the aqueous humor) injection of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    has been used to treat fungal endophthalmitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/12/39112?source=see_link\">",
"     \"Treatment of endogenous endophthalmitis due to Candida species\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/55/2937?source=see_link\">",
"     \"Treatment of endophthalmitis due to molds\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H439193863\">",
"    <span class=\"h3\">",
"     Aerosolized/nebulized",
"    </span>",
"    &nbsp;&mdash;&nbsp;Administration of aerosolized (nebulized)",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    (notably amphotericin B deoxycholate,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/27/18871?source=see_link\">",
"     amphotericin B lipid complex",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/4/1096?source=see_link\">",
"     liposomal amphotericin B",
"    </a>",
"    ) has been reported as a potential strategy in the prevention of invasive fungal infections in select patient populations, such as patients with hematologic malignancies and lung transplant recipients [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/4/19530?source=see_link&amp;anchor=H18984053#H18984053\">",
"     \"Prophylaxis of invasive fungal infections in adults with hematologic malignancies\", section on 'Amphotericin B'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/34/15914?source=see_link&amp;anchor=H24#H24\">",
"     \"Fungal infections following lung transplantation\", section on 'Nebulized amphotericin B'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Adverse effects",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Infusion-related reactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infusion-related reactions, particularly nausea, vomiting, chills, and rigors, are common with IV",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    deoxycholate administration, usually occurring either during infusion (within 15 minutes to 3 hours following initiation) or immediately following administration of the dose. Treatment of amphotericin B-related nausea and vomiting (as well as prevention of subsequent reactions) may require the use of a phenothiazine, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/20/15688?source=see_link\">",
"     promethazine",
"    </a>",
"    (usual adult dose &mdash; 12.5 to 25 mg every 4 to 6 hours PO, IM, IV, or PR),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/28/22984?source=see_link\">",
"     prochlorperazine",
"    </a>",
"    (usual adult dose &mdash; 10 mg IM or IV or 25 mg PR every 4 to 6 hours), or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/2/21544?source=see_link\">",
"     ondansetron",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Phlebitis is a complication that primarily occurs in patients receiving infusions via a small peripheral vein. The addition of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    (usual adult dose &mdash; 25 mg) or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    (usual final concentration &mdash; 500 to 1000",
"    <span class=\"nowrap\">",
"     U/L)",
"    </span>",
"    to the infusion may lessen infusion-related thrombophlebitis, but trials to establish their efficacy are lacking and these adjuncts are not recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other ways to minimize",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    -induced thrombophlebitis include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Infusion of the drug using a central line",
"     </li>",
"     <li>",
"      Use of alternating infusion sites",
"     </li>",
"     <li>",
"      Avoidance of final",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"       amphotericin B",
"      </a>",
"      infusion concentrations exceeding 0.1",
"      <span class=\"nowrap\">",
"       mg/mL",
"      </span>",
"     </li>",
"     <li>",
"      Avoidance of infusion times of less than four hours",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Drug-induced fever, chills, and headache can also be seen. These symptoms can be minimized or prevented by premedication with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    (usual adult dose &mdash; 650 to 1000 mg PO)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/2/33824?source=see_link\">",
"     diphenhydramine",
"    </a>",
"    (usual adult dose &mdash; 25 to 50 mg PO or IV). Nonsteroidal antiinflammatory agents may also be useful in this setting. In a double-blind, placebo-controlled trial,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/38/15978?source=see_link\">",
"     ibuprofen",
"    </a>",
"    administered 30 minutes prior to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    deoxycholate reduced the rate of occurrence of chills from 87 percent to 49 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/22\">",
"     22",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/44/11976?source=see_link\">",
"     Meperidine",
"    </a>",
"    (usual adult dose 25 to 50 mg intramuscularly or intravenously) may reduce amphotericin B-induced chills and rigors. However, meperidine is not routinely recommended for premedication due to its potential side effects.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Nephrotoxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    administration may result in nephrotoxicity. With amphotericin B deoxycholate, a reversible and often transient decline in glomerular filtration rate (GFR) has been described in 5 to 80 percent of patients. The net effect is an elevation (above baseline) in the serum creatinine concentration. Severe renal failure due to amphotericin B deoxycholate alone is less common, but the risks of such reactions increase with diuretic-induced volume depletion or the concurrent administration of another nephrotoxin (such as an aminoglycoside,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    , nephrotoxic cancer chemotherapy, or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/56/29575?source=see_link\">",
"     foscarnet",
"    </a>",
"    ). Amphotericin B deoxycholate is substantially more nephrotoxic than the lipid formulations of amphotericin B. This is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/5/38998?source=see_link\">",
"     \"Amphotericin B nephrotoxicity\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Volume expansion with intravenous sodium chloride (a practice commonly known as \"sodium loading\") may ameliorate the decline in GFR; a total of 500 mL of 0.9 percent sodium chloride is typically given immediately prior to the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    infusion or divided before and after amphotericin B administration. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/5/38998?source=see_link&amp;anchor=H6#H6\">",
"     \"Amphotericin B nephrotoxicity\", section on 'Salt loading'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Electrolyte abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypokalemia, hypomagnesemia, and hyperchloremic acidosis are reflections of an increase in distal tubular membrane permeability following intravenous administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    . Many patients require significant amounts of potassium",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    magnesium supplementation during therapy. Correction of hypokalemia may be difficult in patients with persistent hypomagnesemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42580?source=see_link\">",
"     \"Signs and symptoms of magnesium depletion\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Other reactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;A reversible, normochromic, normocytic anemia occurs in most patients receiving IV",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    , but the onset may be delayed for as long as 10 weeks after the initiation of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/11\">",
"     11",
"    </a>",
"    ]. Transfusions are infrequently required. Elevations in liver function tests have been associated with amphotericin B administration infrequently.",
"   </p>",
"   <p>",
"    Severe allergic reactions (including anaphylaxis) are extremely rare but have been reported.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Patient monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients receiving",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    intravenously should be monitored clinically for infusion-related reactions during and following each administration. Measurements of renal function should be performed daily during initiation of therapy (up to two weeks) and at least weekly thereafter, if stable. Some experts recommend that amphotericin B administration be held or a lipid-based formulation substituted if the plasma creatinine concentration exceeds 2.5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (265",
"    <span class=\"nowrap\">",
"     micromol/L).",
"    </span>",
"   </p>",
"   <p>",
"    Serum",
"    electrolytes (particularly potassium and magnesium) should be assessed at baseline and at least twice weekly throughout therapy. More frequent monitoring is recommended for patients experiencing hypokalemia and hypomagnesemia as a result of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    administration. Complete blood counts should be measured weekly throughout therapy. Monitoring of liver function tests is usually not necessary unless the patient has clinical signs or symptoms suggesting hepatic toxicity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     LIPID-BASED AMPHOTERICIN B FORMULATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lipid-based formulations of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    have been introduced in an attempt to reduce the toxicities associated with amphotericin B deoxycholate [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. Based on animal models and clinical studies, these formulations reduce the risk of amphotericin B-related nephrotoxicity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/5/38998?source=see_link\">",
"     \"Amphotericin B nephrotoxicity\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The available lipid-based formulations are",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/27/18871?source=see_link\">",
"     amphotericin B lipid complex",
"    </a>",
"    (ABLC, Abelcet&reg;),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/57/26518?source=see_link\">",
"     amphotericin B cholesteryl sulfate complex",
"    </a>",
"    (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    colloidal dispersion, ABCD, Amphotec&reg;), and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/4/1096?source=see_link\">",
"     liposomal amphotericin B",
"    </a>",
"    (Ambisome&reg;) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/25,26\">",
"     25,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Safety and efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Few randomized, comparative studies are available that directly compare the safety and efficacy of these formulations to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    deoxycholate. Controlled studies establishing the efficacy of these agents are somewhat limited and often involve patients previously treated with amphotericin B deoxycholate [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a meta-analysis of randomized trials, the incidence of nephrotoxicity was significantly lower with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/4/1096?source=see_link\">",
"       liposomal amphotericin B",
"      </a>",
"      compared with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"       amphotericin B",
"      </a>",
"      deoxycholate (15 versus 33 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/28\">",
"       28",
"      </a>",
"      ]. A lower incidence of nephrotoxicity was also observed with compounded lipid",
"      <span class=\"nowrap\">",
"       emulsion/amphotericin",
"      </span>",
"      B deoxycholate combination preparations compared with amphotericin B deoxycholate (12 versus 31 percent), although we generally avoid such preparations given incomplete and conflicting data regarding their safety, efficacy, and stability. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/5/38998?source=see_link&amp;anchor=H7#H7\">",
"       \"Amphotericin B nephrotoxicity\", section on 'Lipid-based formulations'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H21\">",
"       'Amphotericin B plus fat emulsions'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      A randomized trial compared ABCD with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"       amphotericin B",
"      </a>",
"      deoxycholate in 174 patients with invasive aspergillosis [",
"      <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/29\">",
"       29",
"      </a>",
"      ]. Response rates were similar in both groups (52 and 51 percent, respectively). ABCD was less likely to cause nephrotoxicity than amphotericin B deoxycholate (25 versus 49 percent), but was associated with more infusion-related toxicity (chills in 53 versus 30 percent).",
"     </li>",
"     <li>",
"      In a randomized trial comparing the efficacy of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/4/1096?source=see_link\">",
"       liposomal amphotericin B",
"      </a>",
"      with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"       amphotericin B",
"      </a>",
"      deoxycholate for the treatment of severe disseminated histoplasmosis in 81 AIDS patients, the liposomal formulation resulted in a higher rate of clinical success (88 versus 64 percent) and lower mortality (2 versus 13 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A trial comparing",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/4/1096?source=see_link\">",
"       liposomal amphotericin B",
"      </a>",
"      to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"       amphotericin B",
"      </a>",
"      deoxycholate for empiric therapy in patients with persistent fever and neutropenia found no difference in composite rates of successful treatment and patient outcomes [",
"      <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/31\">",
"       31",
"      </a>",
"      ]. However, significantly fewer patients given liposomal amphotericin B had breakthrough fungal infections, infusion-related fever, chills or rigors, or nephrotoxicity. This was the first trial to note a reduction in infusion-related reactions associated with the liposomal formulation of amphotericin B.",
"     </li>",
"     <li>",
"      Another study, comparing ABLC (5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day) and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/4/1096?source=see_link\">",
"       liposomal amphotericin B",
"      </a>",
"      (3 or 5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day) as empiric therapy in patients with febrile neutropenia persisting after 72 hours of antibacterial treatment, found equivalent clinical outcome but reduced toxicity in the liposomal",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"       amphotericin B",
"      </a>",
"      group at both doses compared to ABLC [",
"      <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/32\">",
"       32",
"      </a>",
"      ]. Fever, chills and rigors, nephrotoxicity, and toxicity-related discontinuation of therapy were all reduced in the liposomal amphotericin B group although all of the infusion reactions except chills and rigors decreased after the first day in the ABLC treated patients.",
"     </li>",
"     <li>",
"      Other open studies have reported successful use of these products in the treatment of invasive candidiasis, aspergillosis, coccidioidomycosis, cryptococcosis, and leishmaniasis [",
"      <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/25,33\">",
"       25,33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A randomized, double-blind trial in patients with invasive candidiasis compared",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/4/1096?source=see_link\">",
"       liposomal amphotericin B",
"      </a>",
"      3",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?43/31/44532?source=see_link\">",
"       micafungin",
"      </a>",
"      , and concluded that micafungin was as effective and better tolerated [",
"      <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/4/1096?source=see_link\">",
"     Liposomal amphotericin B",
"    </a>",
"    has a lower incidence of infusion-related reactions than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    deoxycholate. However, there is a unique group of infusion reactions that can occur with liposomal amphotericin B. These include chest pain, dyspnea, hypoxia, abdominal pain, flushing, and urticaria, and generally respond to therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/2/33824?source=see_link\">",
"     diphenhydramine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Electrolyte abnormalities, such as hypokalemia, hypomagnesemia, and hyperchloremic acidosis, may occur following the administration of both lipid and deoxycholate formulations of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    . (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Electrolyte abnormalities'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Pharmacokinetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lipid-based formulations of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    differ significantly in pharmacokinetic profile from amphotericin B deoxycholate and from each other [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/23\">",
"     23",
"    </a>",
"    ]. As an example, ABLC appears to be taken up rapidly by the reticuloendothelial system and demonstrates high tissue distribution, lower serum concentrations, and a prolonged elimination half-life when compared to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/4/1096?source=see_link\">",
"     liposomal amphotericin B",
"    </a>",
"    . By contrast, liposomal amphotericin B demonstrates a significantly lower volume of distribution, which results in high serum concentrations, and a shorter elimination half-life than does ABLC or amphotericin B deoxycholate. Although lipid formulations of amphotericin B reach detectable levels in pleural fluid, these levels are often below the minimum inhibitory concentration required for some yeasts and dimorphic fungi [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Dosing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Doses of ABLC are generally 5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day. The dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/4/1096?source=see_link\">",
"     liposomal amphotericin B",
"    </a>",
"    ranges from 3 to 5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day (depending upon the indication), whereas ABCD is most commonly administered at doses ranging from 3 to 4",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day.",
"   </p>",
"   <p>",
"    A randomized trial examining the impact of escalating the doses of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/4/1096?source=see_link\">",
"     liposomal amphotericin B",
"    </a>",
"    for the first two weeks of therapy to 10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day demonstrated increases in treatment-related nephrotoxicity without increased efficacy compared with standard dosing of 3",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The recommended dosing of lipid-based formulations of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    for each fungal disease is discussed in detail separately. (See",
"    <a class=\"local\" href=\"#H1\">",
"     'Introduction'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Cost",
"    </span>",
"    &nbsp;&mdash;&nbsp;The drug acquisition cost of a lipid-based formulation of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    is significantly higher than that of amphotericin B deoxycholate, and may exceed $200 per day (depending upon the formulation and contract pricing). Pharmacoeconomic analyses have been performed to assess whether or not this increase in cost compared with amphotericin B deoxycholate can be offset by reductions in toxicity and the costs associated with adverse reactions. A multicenter trial of 414 patients with febrile neutropenia showed that hospital costs were significantly higher for the group receiving",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/4/1096?source=see_link\">",
"     liposomal amphotericin B",
"    </a>",
"    compared with amphotericin B deoxycholate as first-line empiric therapy ($48,962 versus $43,184) based upon the cost of the drug [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/38\">",
"     38",
"    </a>",
"    ]. However, when the cost of the study drug was excluded, hospital costs were lower for the liposomal amphotericin B group, which was probably due to the increased cost of the management of the nephrotoxicity associated with amphotericin B deoxycholate. The authors concluded that both drug cost and risks for nephrotoxicity impact the cost-effectiveness of liposomal amphotericin B.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Amphotericin B plus fat emulsions",
"    </span>",
"    &nbsp;&mdash;&nbsp;It has been suggested that mixing",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    deoxycholate with fat emulsions may reduce renal dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/28\">",
"     28",
"    </a>",
"    ] and infusion-related reactions. However, incomplete and conflicting data exist regarding the safety, efficacy, and stability of these mixtures [",
"    <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/39\">",
"     39",
"    </a>",
"    ]. Thus, their use should be considered investigational and is generally discouraged.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     DRUG INTERACTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following interactions are of particular concern with the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    :",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"       Amphotericin B",
"      </a>",
"      should not be given concurrently or sequentially with other nephrotoxic agents, if possible. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/5/38998?source=see_link\">",
"       \"Amphotericin B nephrotoxicity\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients receiving",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29113?source=see_link\">",
"       digoxin",
"      </a>",
"      or skeletal muscle relaxants may be predisposed to toxicity or enhanced effect of these agents following",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"       amphotericin B",
"      </a>",
"      -induced hypokalemia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28072?source=see_link\">",
"       \"Basic approach to arrhythmias due to digoxin toxicity\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      There are data linking",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"       amphotericin B",
"      </a>",
"      and acute pulmonary reactions in patients receiving concomitant leukocyte transfusions, but these reactions also can occur without administering granulocyte transfusions. Infusions of amphotericin B should be separated as far apart as possible from leukocyte transfusions whenever possible [",
"      <a class=\"abstract\" href=\"UTD.htm?14/41/15001/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5151417\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"       Amphotericin B",
"      </a>",
"      is a polyene antifungal agent with activity in vitro against a wide variety of fungal pathogens. Amphotericin B exerts its antifungal effect by disruption of fungal cell wall synthesis because of its ability to bind to sterols, primarily ergosterol, which leads to the formation of pores that allow leakage of cellular components. Amphotericin B is generally considered cidal against susceptible fungi at clinically relevant concentrations. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Activity of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"       amphotericin B",
"      </a>",
"      has been demonstrated in vitro against a wide variety of clinical fungal isolates, including Candida spp, Aspergillus spp, the Mucorales, all of the endemic mycoses, and most hyaline and brown-black molds. Activity has also been demonstrated against the Leishmania. Organisms that are usually resistant to amphotericin B&nbsp;include the organisms that cause chromoblastomycosis, as well as Aspergillus terreus, Candida lusitaniae, Scedosporium spp, and some Fusarium spp. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Spectrum of activity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Because of the toxicities associated with its intravenous use, along with the expanded availability of safer treatment options, it is frequently reserved for patients who have severe, life-threatening invasive fungal infections or who are unable to tolerate alternative antifungal agents. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Little is known about the pharmacokinetics of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"       amphotericin B",
"      </a>",
"      . The pharmacokinetic profiles of the lipid formulations of amphotericin B differ from those of amphotericin B deoxycholate and from each other. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pharmacokinetics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The drug is poorly absorbed (less than 5 percent) after oral administration. As a result, treatment of systemic mycoses requires intravenous administration. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Absorption'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Serum levels are not influenced by hepatic or renal function, or by hemodialysis or peritoneal dialysis. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Metabolism/elimination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Doses of IV",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"       amphotericin B",
"      </a>",
"      deoxycholate range from 0.1 to 1.5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day. The usual dose for most systemic mycoses is 0.5 to 1.0",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Dosing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infusion-related reactions, particularly nausea and vomiting, are common with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"       amphotericin B",
"      </a>",
"      deoxycholate administration. Drug-induced fever, chills, and headache can also be seen. Medications can be given prior to amphotericin B administration to minimize or prevent these adverse effects. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Infusion-related reactions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      With",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"       amphotericin B",
"      </a>",
"      deoxycholate, a reversible and often transient decline in glomerular filtration rate (GFR) has been described. Volume expansion with intravenous sodium chloride (a practice commonly known as \"sodium loading\") may ameliorate the decline in GFR; 500 mL of 0.9 percent sodium chloride is typically given prior to the amphotericin B infusion. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Nephrotoxicity'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/5/38998?source=see_link\">",
"       \"Amphotericin B nephrotoxicity\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hypokalemia, hypomagnesemia, and hyperchloremic acidosis are reflections of an increase in distal tubular membrane permeability. Many patients require potassium",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      magnesium supplementation during therapy. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Electrolyte abnormalities'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lipid-based formulations of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"       amphotericin B",
"      </a>",
"      have been introduced in an attempt to reduce the toxicities associated with amphotericin B deoxycholate. The lipid formulations of amphotericin B are substantially less nephrotoxic than amphotericin B deoxycholate. The pharmacokinetics of these preparations differ significantly from amphotericin B deoxycholate and each other. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Lipid-based amphotericin B formulations'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/5/38998?source=see_link&amp;anchor=H7#H7\">",
"       \"Amphotericin B nephrotoxicity\", section on 'Lipid-based formulations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Doses of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/27/18871?source=see_link\">",
"       amphotericin B lipid complex",
"      </a>",
"      are generally 5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day. The dose of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/4/1096?source=see_link\">",
"       liposomal amphotericin B",
"      </a>",
"      ranges from 3 to 5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day (depending upon the indication), whereas",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/57/26518?source=see_link\">",
"       amphotericin B cholesteryl sulfate complex",
"      </a>",
"      is most commonly administered at doses ranging from 3 to 4",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Dosing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The recommended dosing of the various formulations of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"       amphotericin B",
"      </a>",
"      for each fungal disease is discussed in detail separately. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/1\">",
"      Dismukes WE. Antifungal therapy: lessons learned over the past 27 years. Clin Infect Dis 2006; 42:1289.",
"     </a>",
"    </li>",
"    <li>",
"     McEvoy, G (Ed). American Hospital Formulary Service &mdash; 1996. American Society of Health System Pharmacists, Bethesda, MD, 1996.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/3\">",
"      Kontoyiannis DP, Lewis RE. Antifungal drug resistance of pathogenic fungi. Lancet 2002; 359:1135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/4\">",
"      Steinbach WJ, Benjamin DK Jr, Kontoyiannis DP, et al. Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clin Infect Dis 2004; 39:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/5\">",
"      Meletiadis J, Meis JF, Mouton JW, et al. In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. Antimicrob Agents Chemother 2002; 46:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/6\">",
"      Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev 2007; 20:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/7\">",
"      Daneshmend TK, Warnock DW. Clinical pharmacokinetics of systemic antifungal drugs. Clin Pharmacokinet 1983; 8:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/8\">",
"      Perfect JR, Klotman ME, Gilbert CC, et al. Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients. J Infect Dis 1992; 165:891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/9\">",
"      Riley DK, Pavia AT, Beatty PG, et al. The prophylactic use of low-dose amphotericin B in bone marrow transplant patients. Am J Med 1994; 97:509.",
"     </a>",
"    </li>",
"    <li>",
"     Infectious Diseases Society of America file://www.idsociety.org/Content.aspx?id=9088 (Accessed on May 06, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/11\">",
"      Gallis HA, Drew RH, Pickard WW. Amphotericin B: 30 years of clinical experience. Rev Infect Dis 1990; 12:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/12\">",
"      Eriksson U, Seifert B, Schaffner A. Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial. BMJ 2001; 322:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/13\">",
"      Leu HS, Huang CT. Clearance of funguria with short-course antifungal regimens: a prospective, randomized, controlled study. Clin Infect Dis 1995; 20:1152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/14\">",
"      Jacobs LG, Skidmore EA, Freeman K, et al. Oral fluconazole compared with bladder irrigation with amphotericin B for treatment of fungal urinary tract infections in elderly patients. Clin Infect Dis 1996; 22:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/15\">",
"      Jacobs LG. Fungal urinary tract infections in the elderly: treatment guidelines. Drugs Aging 1996; 8:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/16\">",
"      Fan-Havard P, O'Donovan C, Smith SM, et al. Oral fluconazole versus amphotericin B bladder irrigation for treatment of candidal funguria. Clin Infect Dis 1995; 21:960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/17\">",
"      Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/18\">",
"      Stevens DA, Shatsky SA. Intrathecal amphotericin in the management of coccidioidal meningitis. Semin Respir Infect 2001; 16:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/19\">",
"      Galgiani JN, Ampel NM, Blair JE, et al. Coccidioidomycosis. Clin Infect Dis 2005; 41:1217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/20\">",
"      Keane JR. Cisternal puncture complications. Treatment of coccidioidal meningitis with amphotericin B. Calif Med 1973; 119:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/21\">",
"      Drew RH. Aerosol and other novel administrations for prevention and treatment of invasive aspergillosis. Med Mycol 2009; 47 Suppl 1:S355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/22\">",
"      Gigliotti F, Shenep JL, Lott L, Thornton D. Induction of prostaglandin synthesis as the mechanism responsible for the chills and fever produced by infusing amphotericin B. J Infect Dis 1987; 156:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/23\">",
"      Wong-Beringer A, Jacobs RA, Guglielmo BJ. Lipid formulations of amphotericin B: clinical efficacy and toxicities. Clin Infect Dis 1998; 27:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/24\">",
"      Slain D. Lipid-based amphotericin B for the treatment of fungal infections. Pharmacotherapy 1999; 19:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/25\">",
"      Hiemenz JW, Walsh TJ. Lipid formulations of amphotericin B: recent progress and future directions. Clin Infect Dis 1996; 22 Suppl 2:S133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/26\">",
"      Graybill JR. Lipid formulations for amphotericin B: does the emperor need new clothes? Ann Intern Med 1996; 124:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/27\">",
"      Walsh TJ, Hiemenz JW, Seibel NL, et al. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis 1998; 26:1383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/28\">",
"      Mistro S, Maciel Ide M, de Menezes RG, et al. Does lipid emulsion reduce amphotericin B nephrotoxicity? A systematic review and meta-analysis. Clin Infect Dis 2012; 54:1774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/29\">",
"      Bowden R, Chandrasekar P, White MH, et al. A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients. Clin Infect Dis 2002; 35:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/30\">",
"      Johnson PC, Wheat LJ, Cloud GA, et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med 2002; 137:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/31\">",
"      Walsh TJ, Finberg RW, Arndt C, et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. N Engl J Med 1999; 340:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/32\">",
"      Wingard JR, White MH, Anaissie E, et al. A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group. Clin Infect Dis 2000; 31:1155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/33\">",
"      White MH, Anaissie EJ, Kusne S, et al. Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis. Clin Infect Dis 1997; 24:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/34\">",
"      Kuse ER, Chetchotisakd P, da Cunha CA, et al. Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. Lancet 2007; 369:1519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/35\">",
"      Roden MM, Nelson LD, Knudsen TA, et al. Triad of acute infusion-related reactions associated with liposomal amphotericin B: analysis of clinical and epidemiological characteristics. Clin Infect Dis 2003; 36:1213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/36\">",
"      Weiler S, Bellmann-Weiler R, Joannidis M, Bellmann R. Penetration of amphotericin B lipid formulations into pleural effusion. Antimicrob Agents Chemother 2007; 51:4211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/37\">",
"      Cornely OA, Maertens J, Bresnik M, et al. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis 2007; 44:1289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/38\">",
"      Cagnoni PJ, Walsh TJ, Prendergast MM, et al. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. J Clin Oncol 2000; 18:2476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/41/15001/abstract/39\">",
"      Sievers TM, Kubak BM, Wong-Beringer A. Safety and efficacy of Intralipid emulsions of amphotericin B. J Antimicrob Chemother 1996; 38:333.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 476 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-14.112.150.18-37D25D05A2-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_41_15001=[""].join("\n");
var outline_f14_41_15001=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H5151417\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SPECTRUM OF ACTIVITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H248502\">",
"      AMPHOTERICIN B DEOXYCHOLATE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Pharmacokinetics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Absorption",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Distribution",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Metabolism/elimination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Dosing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Method of administration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H439193761\">",
"      - Intravenous",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H439193603\">",
"      - Bladder irrigation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H439193798\">",
"      - Intraperitoneal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H463493101\">",
"      - Intrathecal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H439193919\">",
"      - Intravitreal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H439193863\">",
"      - Aerosolized/nebulized",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Adverse effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Infusion-related reactions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Nephrotoxicity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Electrolyte abnormalities",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Other reactions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Patient monitoring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      LIPID-BASED AMPHOTERICIN B FORMULATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Safety and efficacy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Pharmacokinetics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Dosing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Cost",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Amphotericin B plus fat emulsions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      DRUG INTERACTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5151417\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/5/38998?source=related_link\">",
"      Amphotericin B nephrotoxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28072?source=related_link\">",
"      Basic approach to arrhythmias due to digoxin toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/55/17271?source=related_link\">",
"      Coccidioidal meningitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21848?source=related_link\">",
"      Coccidioidomycosis in compromised hosts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/8/13449?source=related_link\">",
"      Cryptococcal infection outside the central nervous system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/6/9321?source=related_link\">",
"      Diagnosis and treatment of disseminated histoplasmosis in non-HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/26/1449?source=related_link\">",
"      Diagnosis and treatment of histoplasmosis in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/23/21881?source=related_link\">",
"      Diagnosis and treatment of pulmonary histoplasmosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/61/40919?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of cryptococcal meningoencephalitis in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/34/15914?source=related_link\">",
"      Fungal infections following lung transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/27/8631?source=related_link\">",
"      Fungal peritonitis in continuous peritoneal dialysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/51/39734?source=related_link\">",
"      Management of pulmonary sequelae and complications of coccidioidomycosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/11/26807?source=related_link\">",
"      Manifestations and treatment of extrapulmonary coccidioidomycosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/46/6890?source=related_link\">",
"      Mucormycosis (zygomycosis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/4/19530?source=related_link\">",
"      Prophylaxis of invasive fungal infections in adults with hematologic malignancies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42580?source=related_link\">",
"      Signs and symptoms of magnesium depletion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/42/3753?source=related_link\">",
"      Treatment and prevention of Fusarium infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/18/28970?source=related_link\">",
"      Treatment and prevention of invasive aspergillosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/13/29912?source=related_link\">",
"      Treatment of blastomycosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/13/29914?source=related_link\">",
"      Treatment of candidemia and invasive candidiasis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/54/15210?source=related_link\">",
"      Treatment of cryptococcal meningoencephalitis and disseminated infection in HIV seronegative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/12/39112?source=related_link\">",
"      Treatment of endogenous endophthalmitis due to Candida species",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/55/2937?source=related_link\">",
"      Treatment of endophthalmitis due to molds",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/0/34822?source=related_link\">",
"      Treatment of sporotrichosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_41_15002="Developmental milestones 12 through 24 mos A";
var content_f14_41_15002=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F75336%7EPEDS%2F55365&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F75336%7EPEDS%2F55365&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 630px\">",
"   <div class=\"ttl\">",
"    Developmental milestones: 12 through 24 months",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 610px; height: 786px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     &copy; 2007 Chris Johnson, MD, AAP Council on Children with Disabilities. Adapted with permission and contributions from: Frances Page Glascoe, PhD and Nicholas Robertshaw, authors of PEDS:Developmental Milestones; Franklin Trimm, MD, Vice Chair of Pediatrics, USA/APA Education Committee; the Center for Disease Control \"Act Early\" Initiative; the National Institute for Literacy/Reach Out and Read; and the Inventory of Early Development by Albert Brigance published by Curriculum Associates, Inc. Permission is granted to reproduce these pages on the condition that they are only used as guide to average development and not as a substitute for standardized validated screening for developmental-behavioral problems.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 630px\">",
"   <div class=\"ttl\">",
"    Developmental milestones: 12 through 24 months (continued)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 610px; height: 697px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     &copy; 2007 Chris Johnson, MD, AAP Council on Children with Disabilities. Adapted with permission and contributions from: Frances Page Glascoe, PhD and Nicholas Robertshaw, authors of PEDS:Developmental Milestones; Franklin Trimm, MD, Vice Chair of Pediatrics, USA/APA Education Committee; the Center for Disease Control \"Act Early\" Initiative; the National Institute for Literacy/Reach Out and Read; and the Inventory of Early Development by Albert Brigance published by Curriculum Associates, Inc. Permission is granted to reproduce these pages on the condition that they are only used as guide to average development and not as a substitute for standardized validated screening for developmental-behavioral problems.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_41_15002=[""].join("\n");
var outline_f14_41_15002=null;
var title_f14_41_15003="Uveitis with eye disease alone";
var content_f14_41_15003=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F75844&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F75844&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Uveitis syndromes confined primarily to the eye",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td>",
"       Acute multifocal placoid pigmentary epitheliopathy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Acute retinal necrosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Birdshot choroidopathy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Fuchs' heterochromic cyclitis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Glaucomatocyclitic crisis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Immune recovery (reconstitution) uveitis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Iridocorneal endothelial syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Leber's neuroretinitis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Multifocal evanescent white dot syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pars planitis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Punctate inner choroidopathy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Serpiginous choroidopathy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Subretinal fibrosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Sympathetic ophthalmia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Trauma",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_41_15003=[""].join("\n");
var outline_f14_41_15003=null;
var title_f14_41_15004="Reoperation following repair of aortic dissection";
var content_f14_41_15004=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F80853&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F80853&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    European Society of Cardiology guidelines: reoperation following repair of aortic dissection",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Recommendation",
"       </td>",
"       <td class=\"subtitle1_single\">",
"        Class",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        1. Surgical intervention for",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        I",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Secondary aneurysm in dissected aorta remote from initial repair",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Recurrent dissection or aneurysm formation at previous intervention site",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Graft replacement for gross dehiscence or infection",
"       </td>",
"       <td>",
"        I",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Use of homografts to replace infected protheses",
"       </td>",
"       <td>",
"        I",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4. Endovascular stenting if surgical indication and suitable anatomy",
"       </td>",
"       <td>",
"        IIa",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\" rowspan=\"1\">",
"        Classification",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        <strong>",
"         Class I:",
"        </strong>",
"        Conditions for which there is evidence and/or general agreement that a given procedure or treatment is useful and effective.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"2\" rowspan=\"1\">",
"        <strong>",
"         Class II:",
"        </strong>",
"        Conditions for which there is conflicting evidence and/or a divergence",
"of opinion about the usefulness/efficacy of a procedure or treatment.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"2\" rowspan=\"1\">",
"        <strong>",
"         Class IIa:",
"        </strong>",
"        Weight of evidence/opinion is in favor of usefulness/efficacy.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"2\" rowspan=\"1\">",
"        <strong>",
"         Class IIb:",
"        </strong>",
"        &nbsp;Usefulness/efficacy less well established by evidence/opinion.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        <strong>",
"         Class III:",
"        </strong>",
"        Conditions for which there is evidence and/or general agreement that",
"the procedure/treatment is not useful and in some cases may be harmful.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data reproduced with permission from Erbel, R, Alfonso, F, Boileau, C, et al, Eur Heart J 2001; 22:1642.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_41_15004=[""].join("\n");
var outline_f14_41_15004=null;
var title_f14_41_15005="Causes localized lymphadenopathy in children";
var content_f14_41_15005=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F71073&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F71073&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of localized lymphadenopathy in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Lymph node group",
"       </td>",
"       <td class=\"subtitle1\">",
"        Area of drainage",
"       </td>",
"       <td class=\"subtitle1\">",
"        Causes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Occipital",
"       </td>",
"       <td>",
"        Posterior scalp, neck",
"       </td>",
"       <td>",
"        <p>",
"         Common: Scalp infections (including tinea capitis, lice), insect bites, seborrhea, roseola (human herpesvirus 6, HHV6)",
"        </p>",
"        <p>",
"         Less common: Rubella, acute lymphoblastic leukemia",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Posterior auricular",
"       </td>",
"       <td>",
"        Temporal and parietal scalp",
"       </td>",
"       <td>",
"        Rubella, roseola (HHV6, HHV7)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Anterior auricular (preauricular)",
"       </td>",
"       <td>",
"        Anterior and temporal scalp, anterior ear canal and pinna, lateral conjunctiva and eyelids",
"       </td>",
"       <td>",
"        <p>",
"         Common: Eye or conjuctival infections (eg, adenovirus, oculoglandular syndrome)",
"        </p>",
"        <p>",
"         Less common: Cat scratch disease, tularemia, listeriosis",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Submental",
"       </td>",
"       <td>",
"        Central lower lip, floor of mouth",
"       </td>",
"       <td>",
"        Tongue, gum, buccal mucosal, and dental infections (eg, gingivostomatitis), group B streptococcal infection (in infants &lt;2 months of age)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Submaxillary (submandibular)",
"       </td>",
"       <td>",
"        Cheek, nose, lips, anterior tongue, submandibular gland, buccal mucosa",
"       </td>",
"       <td>",
"        Tongue, gum, buccal mucosal, and dental infections; dental caries; chronically cracked lips",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Cervical",
"       </td>",
"       <td rowspan=\"2\">",
"        Cranium, neck, oropharynx",
"       </td>",
"       <td>",
"        <p>",
"         <strong>",
"          Anterior:",
"         </strong>",
"         Common: Viral upper respiratory infections, infections of pharynx, oral cavity, or head and neck; primary bacterial adenitis, tuberculosis, Epstein-Barr virus, cytomegalovirus, cat scratch disease, tularemia, nontuberculous mycobacterium, mycobacterium tuberculosis",
"        </p>",
"        <p>",
"         Less common: Kawasaki disease, tularemia, toxoplasmosis, non-infectious causes (eg, Hodgkin's disease, lymphosarcoma, neuroblastoma, rhabdomyosarcoma, sarcoidosis)",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Posterior:",
"        </strong>",
"        Toxoplasmosis, Epstein-Barr virus, rubella",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Supraclavicular",
"       </td>",
"       <td>",
"        <p>",
"         Right: Inferior neck and mediastinum",
"        </p>",
"        <p>",
"         Left: Inferior neck, mediastinum, and upper abdomen",
"        </p>",
"       </td>",
"       <td>",
"        Malignancy (lymphoma or metastatic disease)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Axillary",
"       </td>",
"       <td>",
"        Greater part of arm, shoulder, superficial anterior and lateral thoracic and upper abdominal wall",
"       </td>",
"       <td>",
"        <p>",
"         Common: Cat scratch disease, pyogenic infections of upper arms, brucellosis, reactive response to disruption in skin integrity",
"        </p>",
"        <p>",
"         Less common: Brucellosis, Yersinia pestis, rat-bite fever, toxoplasmosis, rheumatologic disease of the hand or wrist",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Epitrochlear",
"       </td>",
"       <td>",
"        Hand, forearm, elbow",
"       </td>",
"       <td>",
"        <p>",
"         Common: Viral diseases, sarcoidosis, tularemia, infection of hands",
"        </p>",
"        <p>",
"         Less common: Cat scratch disease, tularemia, secondary syphilis, rheumatologic disease of the hand or wrist",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Inguinal",
"       </td>",
"       <td>",
"        Leg and genitalia",
"       </td>",
"       <td>",
"        <p>",
"         Common: Genital herpes, primary; syphilis, gonococcal infection, lymphoma",
"        </p>",
"        <p>",
"         Less common: Yersinia pestis, chancroid, lymphogranuloma venereum",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Popliteal",
"       </td>",
"       <td>",
"        Posterior leg and knee",
"       </td>",
"       <td>",
"        Local infection",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      <ol>",
"       <li>",
"        Segal GB, Hall CB. Lymphadenopathy. In: Primary Pediatric Care, 4th ed, Hoekelman RA (Ed), Mosby, St. Louis 2001. p.1192.",
"       </li>",
"       <li>",
"        Perkins SL, Segal GH, Kjeldsberg CR. Work-up of lymphadenopathy in children. Semin Diagn Pathol 1995; 12:284.",
"       </li>",
"       <li>",
"        Malley R. Lymphadenopathy. In: Textbook of Pediatric Emergency Medicine, 5th ed, Fleisher GR, Ludwig S, Henretig FM (Eds), Lippincott Williams and Wilkins, Philadelphia 2006. p.421.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_41_15005=[""].join("\n");
var outline_f14_41_15005=null;
var title_f14_41_15006="Syndromes combined immunodef";
var content_f14_41_15006=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F64286&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F64286&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Combined immunodeficiency syndromes (not SCID)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Syndrome",
"       </td>",
"       <td class=\"subtitle1\">",
"        Gene",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Wiskott-Aldrich syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Wiskott-Aldrich syndrome protein",
"       </td>",
"       <td>",
"        <em>",
"         WAS",
"        </em>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        DNA repair defects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ataxia telangiectasia mutated",
"       </td>",
"       <td>",
"        <em>",
"         ATM",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nijmegen breakage syndrome",
"       </td>",
"       <td>",
"        <em>",
"         NBS1",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        DNA ligase IV",
"       </td>",
"       <td>",
"        <em>",
"         LIG4",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        DNA ligase I",
"       </td>",
"       <td>",
"        <em>",
"         LIG1",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cernunnos/XRCC4-like factor (XLF)",
"       </td>",
"       <td>",
"        <em>",
"         NHEJ1",
"        </em>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        <strong>",
"         DiGeorge syndrome",
"        </strong>",
"       </td>",
"       <td>",
"        22q11 del",
"        <em>",
"         (TBX-1)",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        10p13 del",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Hyper-IgM syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        CD40 ligand (CD40L), or tumor necrosis factor superfamily member 5 (X-linked)",
"       </td>",
"       <td>",
"        <em>",
"         TNFSF5",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        CD40, or tumor necrosis factor receptor superfamily member 5",
"       </td>",
"       <td>",
"        <em>",
"         TNFRSF5",
"        </em>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        X-linked lymphoproliferative syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Signaling lymphocyte activation molecule (SLAM)-associated protein (SAP)",
"       </td>",
"       <td>",
"        <em>",
"         SH2D1A",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        X-linked inhibitor of apoptosis (XIAP)",
"       </td>",
"       <td>",
"        <em>",
"         BIRC4",
"        </em>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        CXC chemokine receptor 4",
"       </td>",
"       <td>",
"        <em>",
"         CXCR4",
"        </em>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Defects of nuclear factor-kappa-B (NF-kB) regulation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        IkB kinase gamma chain (IKKg), or NF-kB essential modifier (NEMO)",
"       </td>",
"       <td>",
"        <em>",
"         IKBKG",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Inhibitor of kappa B alpha (IkBa), or NF-kB inhibitor alpha (NFKBIA)",
"       </td>",
"       <td>",
"        <em>",
"         IKBA",
"        </em>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Defects of store-operated Ca2+ entry via CRAC channels",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        ORAI1/calcium release-activated calcium modulator 1 (CRACM1)",
"       </td>",
"       <td>",
"        <em>",
"         ORAI1",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Stromal interaction-molecule",
"       </td>",
"       <td>",
"        <em>",
"         STIM1",
"        </em>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Toll-like receptor associated defects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Interleukin-1 receptor-associated kinase 4",
"       </td>",
"       <td>",
"        <em>",
"         IRAK4",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        UNC93B1",
"       </td>",
"       <td>",
"        <em>",
"         UNC93B1",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Toll-like receptor 3",
"       </td>",
"       <td>",
"        <em>",
"         TLR3",
"        </em>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        T cell receptor complex disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        T cell receptor alpha subunit constant",
"       </td>",
"       <td>",
"        <em>",
"         TRAC",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        CD8",
"       </td>",
"       <td>",
"        <em>",
"         CD8",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        CD3 gamma",
"       </td>",
"       <td>",
"        <em>",
"         CD3G",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"2\">",
"        MHC class II gene transcription complex",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        CIITA (complementation group A)",
"       </td>",
"       <td class=\"sublist_other\">",
"        <em>",
"         MHC2TA",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        RFXANK (complementation group B)",
"       </td>",
"       <td class=\"sublist_other\">",
"        <em>",
"         RFXANK",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        RFX5 (complementation group C)",
"       </td>",
"       <td class=\"sublist_other\">",
"        <em>",
"         RFX5",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        RFXAP (complementation group D)",
"       </td>",
"       <td class=\"sublist_other\">",
"        <em>",
"         RFXAP",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"2\">",
"        MHC class I",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Transporters of antigenic peptides 1 and 2",
"       </td>",
"       <td class=\"sublist_other\">",
"        <em>",
"         TAP1, TAP2",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        TAP binding protein (tapasin)",
"       </td>",
"       <td class=\"sublist_other\">",
"        <em>",
"         TAPBP",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Zeta associated protein of 70 kd",
"       </td>",
"       <td>",
"        <em>",
"         ZAP70",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lymphocyte-specific protein-tyrosine kinase (LCK or p561 ck)",
"       </td>",
"       <td>",
"        <em>",
"         LCK",
"        </em>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Other defects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Caspase-8",
"       </td>",
"       <td>",
"        <em>",
"         CASP8",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Interleukin-2 receptor alpha, or CD25",
"       </td>",
"       <td>",
"        <em>",
"         IL2RA",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        CD27 (tumor necrosis factor receptor superfamily, member 7; TNFRSF7)",
"       </td>",
"       <td>",
"        <em>",
"         CD27",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Signal transducer and activator of transcription 5b (STAT5b)",
"       </td>",
"       <td>",
"        <em>",
"         STAT5B",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Purine nucleoside phosphorylase",
"       </td>",
"       <td>",
"        <em>",
"         NP",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nezelof syndrome",
"       </td>",
"       <td>",
"        Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dedicator of cytokinesis 8",
"       </td>",
"       <td>",
"        <em>",
"         DOCK8",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Winged-helix nude, or Forkhead box N1",
"       </td>",
"       <td>",
"        <em>",
"         FOXN1",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hypomorphic RAG1 and RAG2 mutations",
"       </td>",
"       <td>",
"        RA",
"        <em>",
"         G1, RAG2",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Serine threonine kinase 4 (STK4; mammalian sterile 20-like protein 1, MST1)",
"       </td>",
"       <td>",
"        <em>",
"         STK4",
"        </em>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <p>",
"     &nbsp;",
"    </p>",
"    <div class=\"footnotes\">",
"     SCID: severe combined immunodeficiency.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_41_15006=[""].join("\n");
var outline_f14_41_15006=null;
var title_f14_41_15007="Precipitin curve immune complex";
var content_f14_41_15007=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F68456&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F68456&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 516px\">",
"   <div class=\"ttl\">",
"    Precipitin curve demonstrating influence of antigen: antibody ratio on size of immune complexes and amount of precipitated immune complexes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 496px; height: 360px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The antigens and antibodies circled with dashed lines are in precipitates. Other antigens and antibodies remain in solution.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_41_15007=[""].join("\n");
var outline_f14_41_15007=null;
